NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Business Description and Basis of Presentation
Description of Business
The accompanying audited consolidated financial statements reflect the financial position, results of operations, comprehensive income, cash flows, and changes in shareholders' equity of Sensata Technologies Holding plc ("Sensata plc"), a public limited company incorporated under the laws of England and Wales, and its consolidated subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," and "us."
We are a global industrial technology company that develops, manufactures, and sells sensors and sensor-rich solutions, electrical protection components and systems, and other products. Our sensors are used by our customers to translate a physical parameter, such as pressure, temperature, position, or location of an object, into electronic signals that our customers’ products and solutions can act upon. Our electrical protection portfolio (which includes both components and systems) is composed of various switches, fuses, energy storage systems, high-voltage distribution units, controllers, and software, and includes high-voltage contactors and other products embedded within systems to maximize their efficiency and performance and ensure safety. Other products and services we provide include power conversion systems, the latter of which include converters, and rectifiers for renewable energy generation, green hydrogen production, electric vehicle charging stations, and microgrid applications, as well as industrial and defense applications.
Sensata plc conducts its operations through subsidiary companies that operate business and product development centers primarily in Belgium, Bulgaria, China, Denmark, India, Japan, the Netherlands, South Korea, the United Kingdom (the "U.K."), and the United States (the "U.S."); and manufacturing operations primarily in Bulgaria, China, Malaysia, Mexico, the U.K., and the U.S.
We present financial information for three reportable segments, Automotive, Industrials, and Aerospace, Defense, and Commercial Equipment. Additionally, our business strategy involves leveraging new and emerging technologies, which complement our existing product offerings, and we refer to these trends collectively as “megatrends.” Our operating segments’ performance is primarily evaluated based on segment operating income. In the three months ended March 31, 2025, we realigned the definition of segment operating income to include megatrend costs, which were previously excluded from segment operating income and included in corporate and other costs.
In the three months ended December 31, 2025, we realigned our business as a result of organizational changes that better allocate our resources to support changes to our business strategy. These changes resulted in the dissolution of our prior segments, Performance Sensing and Sensing Solutions, and the creation of three new segments. Our Automotive segment includes both Automotive and Aftermarket businesses. The Industrials segment includes our Industrial and Dynapower businesses. The Aerospace, Defense, and Commercial Equipment segment includes our Aerospace and Commercial Equipment businesses. Results of the Insights Business, which was sold during the third quarter of 2024, are presented in the Other non-operating segment, which is not aggregated within any of our reportable segments. Our new operating structure allows us to more effectively allocate capital and investment dollars based on different end market and growth dynamics in each of these segments. Prior year amounts in this Annual Report on Form 10-K (this "Report") have been recast to reflect this realignment. Refer to Note 20: Segment Reporting for additional information.
Basis of Presentation
The accompanying audited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP" or "U.S. GAAP") and present separately our financial position, results of operations, comprehensive income, cash flows, and changes in shareholders’ equity.
All intercompany balances and transactions have been eliminated. All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in millions, unless otherwise indicated. We round amounts in the consolidated financial statements to millions within tables and text (unless otherwise specified) and calculate all percentages and per-share data from underlying whole-dollar amounts. Thus, certain amounts may not foot, crossfoot, or recalculate based on reported numbers due to rounding. Certain reclassifications have been made to prior periods to conform to current period presentation.
2. Significant Accounting Policies
Use of Estimates
The preparation of consolidated financial statements in accordance with GAAP requires us to exercise our judgment in the process of applying our accounting policies. It also requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingencies at the date of the financial statements, and the reported amounts of net revenue and expense during the reporting periods.
Estimates are used when accounting for certain items such as: allowance for doubtful accounts and sales returns; inventory obsolescence; asset impairments (including goodwill and other intangible assets); contingencies; the value of certain equity awards and the measurement of share-based compensation; the determination of accrued expenses; certain asset valuations; accounting for income taxes; the useful lives of plant and equipment; measurement of our post-retirement benefit obligations; and with respect to business combinations, valuation of contingent consideration and the identification, valuation, and determination of useful lives of acquired identifiable intangible assets. The accounting estimates used in the preparation of the consolidated financial statements may change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. Actual results may materially differ from those estimates.
Revenue Recognition
We recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods. In order to achieve this, we use the five-step model outlined in Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers. This five-step model requires us to identify the contract with the customer, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to the performance obligations, and recognize revenue as we satisfy the performance obligations.
The vast majority of our contracts, as defined in FASB ASC Topic 606, are customer purchase orders that require us to transfer specified quantities of tangible products to our customers. These performance obligations are generally satisfied within a short period of time. We have elected the practical expedient in ASC Topic 606 to not disclosures our remaining performance obligations as these obligations are generally less than one year in duration. Amounts billed to our customers for shipping and handling after control has transferred are recognized as revenue and the related costs that we incur are presented in cost of revenue. Our contract terms generally require the customer to make payment on negotiated terms after the shipment date. We exclude from our determination of the transaction price value-added tax and other similar taxes.
Our performance obligations are satisfied, and revenue is recognized, when control of the product is transferred to the customer. The transfer of control generally occurs at the point in time the product is shipped from our warehouse or, less often, at the point in time it is received by the customer, depending on the specific terms of the arrangement.
Our standard terms of sale provide our customers with a limited warranty against faulty workmanship and the use of defective materials, which is not considered a distinct performance obligation in accordance with FASB ASC Topic 606. Depending on the product, we generally provide such warranties for a period of three years after the date we ship the product to our original equipment manufacturer customers or for a period of twelve months after the date the customer resells our product to the end consumer, whichever comes first. Our liability associated with this warranty is, at our option, to repair the product, replace the product, or provide the customer with a credit.
Refer to Note 3: Revenue Recognition for additional information related to the net revenue recognized in the consolidated statements of operations.
Share-Based Compensation
We measure at fair value any new or modified share-based compensation arrangements with employees, such as stock options and restricted securities, and recognize as compensation expense that fair value over the requisite service period in accordance with FASB ASC Topic 718, Compensation—Stock Compensation. Share-based compensation expense is recognized as a component of selling, general and administrative ("SG&A") expense.
Share-based awards may be subject to either cliff vesting (i.e., the entire award vests on a particular date) or graded vesting (i.e., portions of the award vest at different points in time). In accordance with FASB ASC Topic 718, compensation expense associated with share-based awards subject to cliff vesting must be recognized on a straight-line basis. For awards without performance conditions that are subject to graded vesting, we recognize compensation expense on a straight-line basis over the service period. Awards that are subject to both graded vesting and performance conditions are expensed on an accelerated basis
over the service period.
We grant restricted securities for which vesting is contingent only upon service conditions, those that are also subject to performance conditions, and, beginning in fiscal year 2023, those that are subject to conditions based on the attainment of certain market criteria relative to peer companies (the latter referred to as "Market PRSUs").
The fair value of Market PRSUs is estimated at grant date using a Monte Carlo simulation, which requires the use of various assumptions, including the stock price volatility, dividend rate, and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period.
Other restricted securities are valued using the closing price of our ordinary shares on the New York Stock Exchange (the "NYSE") on the grant date. Certain of our restricted securities include performance conditions, which require us to estimate the probable outcome of the performance condition. Compensation expense is recognized if it is probable that the performance condition will be achieved.
We recognize share-based compensation expense net of estimated forfeitures as permitted by FASB ASC Topic 718. Accordingly, we only recognize compensation expense for those awards expected to vest over the requisite service period. Compensation expense recognized for each award, except for Market PSUs, ultimately reflects the number of units that actually vest.
Refer to Note 4: Share-Based Compensation for additional information related to share-based compensation.
Financial Instruments
Our material financial instruments include derivative instruments, debt instruments, equity investments, trade accounts receivable, and trade accounts payable.
Derivative financial instruments
We account for derivative financial instruments in accordance with FASB ASC Topic 820, Fair Value Measurement and FASB ASC Topic 815, Derivatives and Hedging. In accordance with FASB ASC Topic 815, we recognize all derivatives on the balance sheet at fair value. The fair value of our derivative financial instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected net cash flows of each instrument. These analyses utilize observable market-based inputs, including foreign currency exchange rates and commodity forward curves, and reflect the contractual terms of these instruments, including the period to maturity.
Derivative instruments that are designated and qualify as hedges of the exposure to changes in the fair value of an asset, liability, or commitment, and that are attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivative instruments that are designated and qualify as hedges of the exposure to variability in expected future cash flows are considered cash flow hedges. Derivative instruments may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Currently, all of our derivative instruments that are designated as accounting hedges are cash flow hedges.
The accounting for changes in the fair value of our cash flow hedges depends on whether we have elected to designate the derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In accordance with FASB ASC Topic 815, both the effective and ineffective portions of changes in the fair value of derivatives designated and qualifying as cash flow hedges are recognized in accumulated other comprehensive loss and are subsequently reclassified into earnings in the period in which the hedged forecasted transaction affects earnings. Changes in the fair value of derivative instruments that are not designated as accounting hedges are recognized immediately in other, net. Refer to Note 16: Shareholders' Equity and Note 19: Derivative Instruments and Hedging Activities for additional information related to the reclassification of amounts from accumulated other comprehensive loss into earnings.
We present the cash flows arising from our derivative financial instruments in a manner consistent with the presentation of cash flows that relate to the underlying hedged items.
We incorporate credit valuation adjustments to appropriately reflect both our own non-performance risk and the respective counterparty’s non-performance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of non-performance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees. We do not offset the fair value amounts recognized for derivative instruments against fair value amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral. We maintain derivative instruments with major financial institutions of investment grade credit rating and monitor
the amount of credit exposure to any one issuer. We believe there are no significant concentrations of risk associated with our derivative instruments.
Refer to Note 19: Derivative Instruments and Hedging Activities for additional information related to our derivative instruments.
Debt instruments
A premium or discount on a debt instrument is recognized on the balance sheet as an adjustment to the carrying value of the debt liability. In general, amounts paid to creditors are considered a reduction in the proceeds received from the issuance of the debt and are accounted for as a component of the premium or discount on the issuance, not as an issuance cost.
Direct and incremental costs associated with the issuance of debt instruments such as legal fees, printing costs, and underwriters' fees, among others, paid to parties other than creditors, are also reported and presented as a reduction of debt on the consolidated balance sheets.
Debt issuance costs and premiums or discounts are amortized over the term of the respective financing arrangement using the effective interest method. Amortization of these amounts is included as a component of interest expense in the consolidated statements of operations.
When accounting for debt repayment transactions, we apply the provisions of FASB ASC Subtopic 470-50, Modifications and Extinguishments. Our evaluation of the accounting under FASB ASC Subtopic 470-50 is done on a creditor-by-creditor basis in order to determine if the terms of the debt are substantially different and, as a result, whether to apply modification or extinguishment accounting. In the event that an individual holder of existing debt did not invest in new debt, we apply extinguishment accounting. Borrowings associated with individual holders of new debt that are not holders of existing debt are accounted for as new issuances.
Refer to Note 14: Debt for additional information related to our debt instruments and transactions.
Equity investments
We generally measure equity investments either at fair value, with changes to fair value recognized in net income, or, in certain instances, by use of a measurement alternative prescribed in FASB ASC Topic 321, Investments - Equity Securities. Under the measurement alternative, such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer.
Refer to Note 18: Fair Value Measures for additional information related to our measurement of equity investments.
Trade accounts receivable
Trade accounts receivable are recognized at invoiced amounts and do not bear interest. Trade accounts receivable are reduced by an allowance for losses on receivables. Concentrations of risk with respect to trade accounts receivable are generally limited due to the large number of customers in various industries and their dispersion across several geographic areas. Although we do not foresee that credit risk associated with these receivables will deviate from historical experience, collection is dependent upon the financial stability of these individual customers. We estimate an allowance for credit losses on trade accounts receivable at an amount that represents our estimated expected credit losses over the lifetime of our receivables, and we assume that current conditions as of the balance sheet date will not change during the remaining life of the asset. No customer exceeded 10% of our net revenue or accounts receivable in any of the years ended December 31, 2025, 2024, and 2023.
Trade accounts payable
Trade accounts payable represent liabilities for products provided to us by suppliers prior to the end of the reporting period that are unpaid. Trade accounts payable are short term liabilities and are recognized at invoiced amounts and do not bear interest.
Allowance for Losses on Receivables
The allowance for losses on receivables is used to present accounts receivable, net at an amount that represents our estimate of the related transaction price recognized as revenue in accordance with FASB ASC Topic 606. The allowance represents an estimate of expected credit losses over the lifetime of our receivables, even if the loss is considered remote, and reflects expected recoveries of amounts previously written-off. We estimate the allowance on the basis of specifically identified receivables that are evaluated individually for collectability. We assume that current conditions as of the balance sheet date will not change during the remaining life of the asset. The allowance for losses on receivables also includes an allowance for sales
returns (variable consideration).
Management judgments are used to determine when to charge off uncollectible trade accounts receivable. We base these judgments on the age of the receivable, credit quality of the customer, current economic conditions, and other factors that may affect a customer’s ability and intent to pay. Customers are generally not required to provide collateral for purchases.
Losses on receivables have not historically been significant.
Goodwill and Other Intangible Assets
Businesses acquired are recognized at their fair value on the date of acquisition, with the excess of the purchase price over the fair value of identifiable assets acquired and liabilities assumed recognized as goodwill. Intangible assets acquired may include either definite-lived or indefinite-lived intangible assets, or both.
In accordance with the guidance in FASB ASC Topic 350, Intangibles—Goodwill and Other, goodwill and intangible assets determined to have an indefinite useful life are not amortized. Instead, these assets are evaluated for impairment on an annual basis and whenever events or business conditions change that could indicate that the asset is impaired. We evaluate goodwill and indefinite-lived intangible assets for impairment in the fourth quarter of each fiscal year, unless events occur which trigger the need for an earlier impairment review.
Goodwill
Our reporting units have been identified based on the definitions and guidance provided in FASB ASC Topic 350. Identification of reporting units includes an analysis of the components that comprise each of our operating segments, which considers, among other things, the manner in which we operate our business and the availability of discrete financial information. Components of an operating segment are aggregated to form one reporting unit if the components have similar economic characteristics. We periodically review these reporting units to ensure that they continue to reflect the manner in which the business is operated.
Some assets and liabilities relate to the operations of multiple reporting units. We allocate these assets and liabilities to the related reporting units based on methods that we believe are reasonable and supportable. We apply that allocation method on a consistent basis from year to year. Other assets and liabilities, such as debt, cash and cash equivalents, and property, plant and equipment ("PP&E") associated with our corporate offices, are viewed as being corporate in nature. Accordingly, we do not assign these assets and liabilities to our reporting units.
In the event we reorganize our business, we reassign the assets (including goodwill) and liabilities among the affected reporting units using a reasonable and supportable methodology. As businesses are acquired, we assign assets acquired (including goodwill) and liabilities assumed to a new or existing reporting unit as of the date of the acquisition. In the event a disposal group meets the definition of a business, goodwill is allocated to the disposal group based on the relative fair value of the disposal group to the retained portion of the related reporting unit.
We have the option to first assess qualitative factors to determine whether a quantitative goodwill impairment analysis must be performed. The objective of a qualitative goodwill impairment analysis is to assess whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. We make this assessment based on macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, and other relevant factors as applicable. If we elect not to use this option, or if we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then we prepare a discounted cash flow analysis (and, when applicable, a market multiples approach using comparable companies) to determine whether the carrying value of a reporting unit exceeds its estimated fair value. If the carrying value of a reporting unit exceeds its estimated fair value, we recognize an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB ASC Topic 350.
Indefinite-lived intangible assets
Similar to goodwill, we perform an annual impairment review of our indefinite-lived intangible assets in the fourth quarter of each fiscal year, unless events occur that trigger the need for an earlier impairment review. We have the option to first assess qualitative factors in determining whether it is more likely than not that an indefinite-lived intangible asset is impaired. If we elect not to use this option, or we determine that it is more likely than not that the asset is impaired, we perform a quantitative impairment analysis in which we estimate the fair value of the indefinite-lived intangible asset and compare that amount to its carrying value. We determine fair value by using the appropriate income approach valuation methodology. Impairment, if any, is based on the excess of the carrying value over the fair value of these assets.
Definite-lived intangible assets
Acquisition-related definite-lived intangible assets are amortized on an economic-benefit basis according to the useful lives of the assets, or on a straight-line basis if a pattern of economic benefits cannot be reliably determined. Capitalized software and capitalized software licenses are presented on the consolidated balance sheets as intangible assets. Capitalized software licenses are amortized on a straight-line basis over the lesser of the term of the license or the estimated useful life of the software. Capitalized software is amortized on a straight-line basis over its estimated useful life.
Reviews are regularly performed to determine whether facts or circumstances exist that indicate that the carrying values of our definite-lived intangible assets are impaired. If we determine that such facts or circumstances exist, we estimate the recoverability of the related asset or asset group (at the lowest level of identifiable cash flows) by comparing the projected undiscounted net cash flows associated with this asset or asset group to its carrying value. If the sum of the projected undiscounted net cash flows is less than the carrying value of an asset or asset group, the impairment charge is measured as the excess of the carrying value over the fair value of that asset or asset group. We determine fair value by using the appropriate income approach valuation methodology, depending on the nature of the definite-lived intangible asset.
Refer to Note 11: Goodwill and Other Intangible Assets, Net for additional information related to our goodwill and other intangible assets.
Research and Development Expense
Research and development expense ("R&D") expense consists of costs related to product design and development activities. Our development expense is typically associated with engineering core technology platforms to specific applications and engineering major upgrades that improve the functionality or reduce the cost of existing products. Costs related to modifications of existing products for use by new and existing customers in familiar applications are presented in cost of revenue and not included in R&D expense. R&D costs are generally expensed as incurred.
Income Taxes
We estimate our provision for (or benefit from) income taxes in each of the jurisdictions in which we operate. The provision for (or benefit from) income taxes includes both our current and deferred tax expense. Our deferred tax expense is measured using the asset and liability method, under which deferred income taxes are recognized to reflect the future tax consequences of differences between the tax bases of assets and liabilities and their financial reporting amounts at each balance sheet date, based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to reverse or settle. The effect on deferred tax assets and liabilities of a change in statutory tax rates is recognized in the consolidated statements of operations as an adjustment to income tax expense in the period that includes the enactment date.
In measuring our deferred tax assets, we consider all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is needed for all or some portion of the deferred tax assets. If it is determined that it is more likely than not that future tax benefits associated with a deferred tax asset will not be realized, a valuation allowance is provided. As a result, we maintain valuation allowances against the deferred tax assets in jurisdictions that have incurred losses in recent periods and in which it is more likely than not that such deferred tax assets will not be utilized in the foreseeable future.
In accordance with FASB ASC Topic 740, Income Taxes, we record uncertain tax positions on the basis of a two-step process. First, we determine whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position. Second, for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is greater than 50 percent likely to be realized upon ultimate settlement with the relevant tax authority. Significant judgment is required in evaluating whether our tax positions meet this two-step process. The more-likely-than-not recognition threshold must be met in each reporting period to support continued recognition of any tax benefits claimed, both in the current year, as well as any year which remains open for review by the relevant tax authority at the balance sheet date. Penalties and interest related to uncertain tax positions may be classified as either income taxes or another expense line item in the consolidated statements of operations. We classify interest and penalties related to uncertain tax positions within the provision for (or benefit from) income taxes line of the consolidated statements of operations.
Refer to Note 7: Income Taxes for additional information related to our income taxes.
Inventories
Inventories are stated at the lower of cost or estimated net realizable value. The cost of raw materials, work-in-process, and finished goods is determined based on a first-in, first-out basis and includes material, labor, and applicable manufacturing
overhead. We conduct quarterly inventory reviews for salability and obsolescence, and inventories considered unlikely to be sold are adjusted to net realizable value.
Refer to Note 9: Inventories for additional information related to our inventory balances.
Leases
We account for leases in accordance with the guidance in FASB ASC Topic 842, Leases. We enter into lease agreements for many of our facilities around the world. We occupy leased facilities with initial terms ranging up to 20 years. Our lease agreements may include options to renew for additional periods or to purchase the leased assets and generally require that we pay taxes, insurance, and maintenance costs. Depending on the specific terms of the leases, our obligations are in two forms: finance leases and operating leases. For both forms of leases, we recognize a related lease liability and right-of-use asset on our consolidated balance sheets.
Our lease liabilities are initially measured at the present value of the lease payments not yet paid, discounted using our incremental borrowing rate for a period that is comparable to the remaining lease term. We use our incremental borrowing rate, adjusted for collateralization, because the discount rates implicit in our leases are generally not readily determinable.
For finance leases, the consolidated statements of operations include separate recognition of interest on the lease liability and amortization of the right-of-use asset. For operating leases, the consolidated statements of operations include a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a straight-line basis.
Net cash flows from operating activities include (1) interest on finance lease liabilities and (2) payments arising from operating leases. Net cash flows from financing activities include payments of the principal portion of finance lease liabilities.
We also lease certain vehicles and equipment, which generally have a term of one year or less. We have elected to not record leases with a term of one year or less (short-term leases) on the consolidated balance sheets as permitted by FASB ASC Topic 842.
Refer to Note 17: Leases for additional information related to amounts recognized in the consolidated financial statements related to our leases.
Long-Lived Assets
Property, Plant and Equipment, Net
PP&E is stated at historical cost, which for certain qualifying assets includes capitalized interest. In the case of plant and equipment, the historical cost is depreciated on a straight-line basis over its estimated economic useful life. The depreciable lives of plant and equipment are generally as follows:
| | | | | |
| Buildings and improvements | up to 40 years |
| Machinery and equipment | up to 15 years |
Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated economic useful lives of the improvements. Amortization of leasehold improvements is included in depreciation expense.
Expenditures for maintenance and repairs are charged to expense as incurred, whereas major improvements that increase asset values and extend useful lives are capitalized.
Refer to Note 10: Property, Plant and Equipment, Net for additional information related to our PP&E balances.
Leases - Right of Use Assets
Assets held under finance leases are recognized at the lower of the present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense associated with leases is computed using the straight-line method over the shorter of the estimated useful lives of the assets or the period of the related lease, unless ownership is transferred by the end of the lease or there is a bargain purchase option, in which case the asset is depreciated, normally on a straight-line basis, over the useful life that would be assigned if the asset were owned.
Evaluation of long-lived assets for impairment
We re-evaluate the carrying values and estimated useful lives of long-lived assets, or groups of assets (including lease right-of-use assets), whenever events or changes in circumstances indicate that the carrying values of these assets may not be recoverable. We use estimates of undiscounted net cash flows from long-lived assets to determine whether the carrying values of such assets or asset groups are recoverable over the assets’ remaining useful lives. These estimates include assumptions about our future performance and the performance of the end markets we serve. If an asset or asset group is determined to be impaired, the impairment is the amount by which its carrying value exceeds its fair value.
Foreign Currency
Our reporting currency is the USD. We derive a significant portion of our net revenue from markets outside of the U.S. For financial reporting purposes, the functional currency of all of our subsidiaries has historically been the USD because of the significant influence of the USD on our operations. Effective October 1, 2023, the functional currency of the Company's wholly-owned subsidiaries in China changed to the Chinese Renminbi ("CNY").
In certain instances, our subsidiaries enter into transactions that are denominated in a currency other than their functional currency. At the date that such transaction is recognized, each asset, liability, revenue, expense, gain, or loss arising from the transaction is measured and recorded in the functional currency using the exchange rate in effect at that date. At each balance sheet date, recorded monetary balances denominated in a currency other than the functional currency are adjusted to the functional currency using the exchange rate at the balance sheet date, with gains or losses recognized in other, net in the consolidated statements of operations.
For subsidiaries with a functional currency other than the USD, we translate the subsidiary financial statements from their functional currency to USD in accordance with FASB ASC Topic 830, Foreign Currency Matters. According to FASB ASC Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders’ equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported as cumulative translation adjustment ("CTA"), which is a component of other comprehensive income (or loss) and as a component of accumulated other comprehensive loss on the consolidated balance sheets in accordance with FASB ASC Topic 220, Income Statement - Reporting Comprehensive Income.
Cash and Cash Equivalents
Cash comprises cash on hand. Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash, are subject to an insignificant risk of change in value, and have maturities as of the date of purchase of three months or less.
We have established guidelines relative to diversification and maturities of our cash and cash equivalent balances intended to maximize both security and liquidity of our funds. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. As of December 31, 2025 and 2024, most of our cash and cash equivalents balances exceeded federally insured limits and could be at risk of loss.
Pension and Other Post-Retirement Benefits
We sponsor various pension and other post-retirement benefit plans covering our current and former employees in several countries. The funded status of pension and other post-retirement benefit plans, recognized on our consolidated balance sheets as an asset, current liability, or long-term liability, is measured as the difference between the fair value of plan assets and the benefit obligation at the measurement date.
Benefit obligations represent the actuarial present value of all benefits attributed by the pension formula as of the measurement date to employee service rendered before that date. The value of benefit obligations takes into consideration various financial assumptions, including assumed discount rate and the rate of increase in healthcare costs, and demographic assumptions, including compensation rate increases, retirement patterns, employee turnover rates, and mortality rates. We review these assumptions annually.
The discount rate reflects the current rate at which the pension and other post-retirement liabilities could be effectively settled, considering the timing of expected payments for plan participants. It is used to discount the estimated future obligations of the plans to the present value of the liability reflected in the financial statements. In estimating this rate in countries that have a market of high-quality, fixed-income investments, we consider rates of return on these investments included in various bond indices, adjusted to eliminate the effects of call provisions and differences in the timing and amounts of cash outflows related to the bonds. In other countries where a market of high-quality, fixed-income investments does not exist, we estimate the discount
rate using government bond yields or long-term inflation rates.
The expected return on plan assets reflects the average rate of earnings expected on the funds invested to provide for the benefits included in the projected benefit obligation. To determine the expected return on plan assets, we use the fair value of plan assets and consider the historical returns earned by similarly invested assets, the rates of return expected on plan assets in the future, and our investment strategy and asset mix with respect to the plans’ funds.
Changes to benefit obligations may also be initiated by a settlement or curtailment. A settlement of a defined benefit obligation is an irrevocable transaction that relieves us (or the plan) of primary responsibility for the defined benefit obligation and eliminates significant risks related to the obligation and the assets used to carry out the settlement. The settlement of all or more than a minor portion of the pension obligation constitutes an event that requires recognition of all or part of the net actuarial gains or losses deferred in accumulated other comprehensive income/(loss). Our policy is to apply settlement accounting to the extent our year-to date settlements for a given plan exceed the sum of our forecasted full year service cost and interest cost for that particular plan.
A curtailment is an event that significantly reduces the expected years of service of active employees or eliminates for a significant number of employees the accrual of defined benefits for some or all of their future service. The curtailment accounting provisions are applied on a plan-by-plan basis. The total gain or loss resulting from a curtailment is the sum of two distinct elements: (1) prior service cost write-off and (2) curtailment gain or loss. Our policy is that a curtailment event represents one for which we expect a 10% (or greater) reduction in future years of service or an elimination of the accrual of defined benefits for some or all of the future services of 10% (or greater) of the plan's participants.
Contributions made to pension and other post-retirement benefit plans are presented as a component of operating cash flows within the consolidated statements of cash flows. We present the service cost component of net periodic benefit cost in the cost of revenue, R&D, and SG&A expense line items, and we present the non–service components of net periodic benefit cost in other, net.
Refer to Note 13: Pension and Other Post-Retirement Benefits for additional information related to our pension and other post-retirement benefit plans.
Recently issued accounting standards adopted in the current period:
In December 2023, the FASB issued Accounting Standards Update ("ASU") No. 2023-09, Income taxes (Topic 740): Improvements to Income Tax Disclosures, which requires (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) disclosure of income taxes paid disaggregated by jurisdiction. ASU No. 2023-09 also includes certain other updates to improve the effectiveness of income tax disclosures. ASU No. 2023-09 is effective for annual periods beginning after December 31, 2024, and should be applied prospectively, with retrospective application also a permitted option. We prospectively adopted ASU No. 2023-09 on January 1, 2025 and have included the required new annual disclosures in our Annual Report on Form 10-K for the period December 31, 2025. Refer to Note 7: Income Taxes for additional information.
In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient to measure credit losses on current accounts receivable and current contract assets. The practical expedient assumes that current conditions as of the balance sheet do not change for the remaining life of the asset in developing reasonable and supportable forecasts as part of estimating expected credit losses. This ASU is effective for fiscal years beginning after December 15, 2025, and interim periods within those annual reporting periods, with early adoption permitted. We early adopted ASU No. 2025-05 for the year ended December 31, 2025. This adoption did not have a material impact on our consolidated financial statements and disclosures.
Recently issued accounting standards to be adopted in a future period:
In November 2024, the FASB issued ASU No. 2024-03 Income Statement (Topic 220): Reporting Comprehensive Income, which requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU No. 2024-03 does not change or remove current expense presentation requirements within the Consolidated Statements of Operations. However, the amendments require disclosure, on an annual and interim basis, of disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU No. 2024-03 will have on its consolidated financial statements and disclosures.
In September 2025, the FASB issued ASU No. 2025-06, Intangibles-Goodwill and Other - Internal-Use Software (Subtopic
350-40): Targeted Improvements to the Accounting for Internal-Use Software. This update improves the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. ASU No. 2025-06 is effective for annual reporting periods beginning after December 15, 2027, including interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. This ASU can be applied prospectively, retrospectively, or with a modified transition approach. The Company is currently evaluating the impact that the adoption of ASU No. 2025-06 will have on its consolidated financial statements and disclosures.
In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements. This guidance amends existing guidance to simplify the application of hedge accounting, enhance alignment between risk management activities and financial reporting, and provide additional flexibility in the designation and measurement of certain hedging relationships. The amendments included in the five matters addressed in this ASU are intended to better reflect those strategies in financial reporting by enabling entities to achieve and maintain hedge accounting for highly effective economic hedges of forecasted transactions. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU No. 2025-09 will have on its consolidated financial statements and disclosures.
3. Revenue Recognition
We recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods. The majority of our revenue is derived from the sale of tangible products whereby (1) control of the product transfers to the customer at a point in time, (2) we recognize revenue at a point in time, and (3) the underlying contract is a purchase order that establishes a firm purchase commitment for a short period of time. Our standard terms of sale provide our customers with a limited warranty against faulty workmanship and the use of defective materials. Refer to Note 2: Significant Accounting Policies for additional information.
We have elected to apply certain practical expedients that allow for more limited disclosures than those that would otherwise be required by FASB ASC Topic 606, including (1) the disclosure of transaction price allocated to the remaining unsatisfied performance obligations at the end of the period and (2) an explanation of when we expect to recognize the related revenue.
We believe that our geographic regions are the categories that best depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Refer to Note 20: Segment Reporting for additional information.
4. Share-Based Compensation
At our 2021 Annual General Meeting, our shareholders approved the Sensata Technologies Holding plc 2021 Equity Incentive Plan (the "2021 Equity Plan"), which replaced the Sensata Technologies Holding plc First Amended and Restated 2010 Equity Incentive Plan (the "2010 Equity Plan"). The 2021 Equity Plan is substantially similar to the 2010 Equity Plan with some updates based on changes in law and current practices. The purpose of the 2021 Equity Plan is to promote the long-term growth, profitability, and interests of the Company and its shareholders by aiding us in attracting and retaining employees, officers, consultants, advisors, and non-employee directors capable of assuring our future success. All awards granted subsequent to this approval were made under the 2021 Equity Plan. The 2010 Equity Plan was terminated as to the grant of any additional awards, but prior awards remain outstanding in accordance with their terms. As of December 31, 2025, there were 3.3 million ordinary shares available for grants of awards under the 2021 Equity Plan.
Refer to Note 2: Significant Accounting Policies for additional information related to our share-based compensation accounting policies.
Share-Based Compensation Awards
We grant restricted stock unit ("RSU") and performance-based restricted stock unit ("PRSU") awards. We also have stock option awards outstanding, but we have not granted such awards since the year ended December 31, 2019. Throughout this Annual Report on Form 10-K, RSU and PRSU awards are often referred to collectively as "restricted securities."
For option and RSU awards, vesting is typically only subject to service conditions, although they include continued vesting provisions for retirement-eligible employees. For PRSU awards, vesting is also subject to service conditions, however the number of awarded units that ultimately vest also depends on the attainment of certain predefined performance criteria. In the year ended December 31, 2023, we began granting certain Market PRSUs with market performance conditions. These PRSUs are valued using the Monte Carlo simulation. Refer to Note 2: Significant Accounting Policies for additional information.
Options
A summary of stock option activity for the year ended December 31, 2025 is presented in the table below:
| | | | | | | | | | | | | | | | | | | | | | | |
| Number of Options (millions) | | Weighted-Average Exercise Price Per Option | | Weighted-Average Remaining Contractual Term (years) | | Aggregate Intrinsic Value |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Balance as of December 31, 2024 | 0.8 | | | $ | 46.94 | | | 2.3 | | $ | — | |
| | | | | | | |
| Forfeited or expired | (0.1) | | | $ | 55.68 | | | | | |
| Exercised | — | | | $ | — | | | | | |
Balance as of December 31, 2025 | 0.7 | | | $ | 44.55 | | | 1.8 | | $ | — | |
Options vested and exercisable as of December 31, 2025 | 0.7 | | | $ | 44.55 | | | 1.8 | | $ | — | |
No options were exercised in the year ended December 31, 2025. Aggregate intrinsic value of options exercised in the years ended December 31, 2024 and 2023 was $0.4 million and $1.7 million, respectively.
Restricted Securities
We grant RSU awards that vest one-third on the annual anniversary of the grant for three years and PRSU awards that cliff vest three years after the grant date.
In the event of a qualifying termination, any unvested restricted securities that would have otherwise vested within the next six months vest in full on the termination date, and in the event of termination by reason of a covered retirement, any unvested restricted securities remain outstanding on the termination date and subject to continued vesting. For PRSU awards, the number of units that ultimately vest depends on the extent to which certain performance criteria, described in the table below, are met.
A summary of restricted securities granted in the years ended December 31, 2025, 2024, and 2023 is presented below:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Percentage Range of Units That May Vest (1) |
| | | | | 0.0% to 150.0% | | 0.0% to 200.0% |
(Awards in millions) | RSU Awards Granted | | Weighted-Average Grant-Date Fair Value | | PRSU Awards Granted (2) | | Weighted-Average Grant-Date Fair Value | | PRSU Awards Granted | | Weighted-Average Grant-Date Fair Value |
| 2025 | 1.2 | | | $ | 24.16 | | | 0.5 | | | $ | 25.58 | | | — | | | $ | — | |
| 2024 | 1.1 | | | $ | 36.80 | | | 0.3 | | | $ | 37.71 | | | — | | | $ | — | |
| 2023 | 0.6 | | | $ | 48.68 | | | 0.2 | | | $ | 52.72 | | | 0.2 | | | $ | 49.15 | |
__________________________
(1) Represents the percentage range of PRSU award units granted that may vest according to the terms of the awards. The amounts presented within this table do not reflect our current assessment of the probable outcome of vesting based on the achievement or expected achievement of performance conditions.
(2) Approximately 50 percent of these awards represent Market PRSUs that will be evaluated relative to the performance of certain peers as defined in the award agreement. The number of units that ultimately vest will be from 0% to 150%, depending on achievement of these performance criteria.
The fair value of Market PRSUs was estimated on the date of grant (April 2025, 2024 and 2023) using a Monte Carlo simulation pricing model. See Note 2: Significant Accounting Policies for further discussion. The key assumptions used in estimating the grant-date fair value of Market PRSUs for the years ended December 31, 2025, 2024, and 2023 are presented in the table below:
| | | | | | | | | | | |
| For the year ended December 31, 2025 | For the year ended December 31, 2024 | For the year ended December 31, 2023 |
Expected term (years) | 3 | 3 | 3 |
Risk free interest rate | 3.8% | 4.5% | 3.8% |
Dividend yield | 2.0% | 1.3% | 0.9% |
Stock price on valuation date | $24.23 | $36.50 | $50.00 |
Expected volatility | 32% | 31% | 36% |
Compensation expense for the year ended December 31, 2025 reflects our estimate of the probable outcome of the performance
conditions associated with the PRSU awards granted in the years ended December 31, 2025, 2024, and 2023.
A summary of activity related to outstanding unvested restricted securities for the year ended December 31, 2025 is presented in the table below:
| | | | | | | | | | | |
| Restricted Securities (millions) | | Weighted-Average Grant-Date Fair Value |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Balance as of December 31, 2024 | 1.6 | | | $ | 42.06 | |
| Granted | 1.7 | | | $ | 24.60 | |
| Forfeited | (0.6) | | | $ | 33.10 | |
| Vested | (0.6) | | | $ | 26.47 | |
Balance as of December 31, 2025 | 2.1 | | | $ | 30.58 | |
The fair value of restricted securities that vested during the years ended December 31, 2025, 2024, and 2023 was $16.7 million, $33.3 million, and $34.7 million, respectively.
The weighted-average remaining periods (in years) over which the restrictions will lapse as of December 31, 2025, 2024, and 2023 are as follows:
| | | | | | | | | | | | | | | | | |
| As of December 31, |
| 2025 | | 2024 | | 2023 |
| Outstanding | 1.6 | | 1.3 | | 1.2 |
| Expected to vest | 1.7 | | 1.3 | | 1.2 |
The expected to vest restricted securities are calculated based on the application of a forfeiture rate assumption to all outstanding restricted securities as well as our assessment of the probability of meeting the required performance conditions that pertain to the PRSU awards.
Share-Based Compensation Expense
The table below presents non-cash compensation expense related to our equity awards, which is recognized within SG&A expense in the consolidated statements of operations, for the years ended December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| 2025 | | 2024 | | 2023 |
| Stock options | $ | — | | | $ | 0.6 | | | $ | (0.1) | |
| Restricted securities | 25.0 | | | 37.9 | | | 30.1 | |
| Share-based compensation expense | $ | 25.0 | | | $ | 38.5 | | | $ | 30.0 | |
In the years ended December 31, 2025, 2024, and 2023, we recognized $4.0 million, $5.5 million, and $4.5 million, respectively, of income tax benefit associated with share-based compensation expense.
The table below presents unrecognized compensation expense at December 31, 2025 for each class of award and the remaining expected term for this expense to be recognized:
| | | | | | | | | | | |
| Unrecognized Compensation Expense | | Expected Recognition (years) |
| | | |
| Restricted securities | $ | 30.9 | | | 1.8 |
| | | |
5. Restructuring and Other Charges, Net
Transformation Plan
In the year ended December 31, 2025, we committed to a plan to reorganize our business (the “Transformation Plan”). The Transformation Plan, consisting of leadership transitions, involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to competitively reposition ourselves to capture growth from evolving market conditions.
Over the life of the Transformation Plan, we expect to incur restructuring charges of between $13.0 million and $16.0 million, primarily related to reductions-in-force and related site closure costs. All restructuring costs are excluded from segment results.
The majority of the actions under the Transformation Plan are expected to be completed by on or before June 30, 2028. We expect to settle these charges with cash on hand.
2H 2024 Plan
In the year ended December 31, 2024, we committed to a plan to reorganize our business (the “2H 2024 Plan”). The 2H 2024 Plan, consisting of involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to adjust our cost structure and business activities to better align with weaker market demand and continued economic uncertainty in many of our end markets and to take active measures to accelerate our margin recovery.
Over the life of the 2H 2024 Plan, we expect to incur restructuring charges of approximately $18.0 million, primarily related to reductions-in-force. The majority of the actions under the 2H 2024 Plan were completed on or before December 31, 2025 and actions yet to be completed are expected to result in immaterial charges. We expect to settle these charges with cash on hand.
Q3 2023 Plan
In the year ended December 31, 2023, we committed to a plan to reorganize our business (the “Q3 2023 Plan”). The Q3 2023 Plan, consisting of voluntary and involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to adjust our cost structure and business activities to better align with weaker market demand and continued economic uncertainty in many of our end markets and to take active measures to accelerate our margin recovery.
Over the life of the Q3 2023 Plan, we expect to incur restructuring charges of approximately $29.0 million, primarily related to reductions-in-force. The majority of the actions under the Q3 2023 Plan were completed on or before December 31, 2025 and actions yet to be completed are expected to result in immaterial charges. We expect to settle these charges with cash on hand.
Summary
The following table presents the components of restructuring and other charges, net for the years ended December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
Transformation Plan | | $ | 6.9 | | | $ | — | | | $ | — | |
2H 2024 Plan, net | | 5.7 | | | 11.8 | | | — | |
Q3 2023 Plan, net | | 4.2 | | | 0.4 | | | 23.5 | |
| | | | | | |
Other restructuring and other charges, net | | | | | | |
Severance costs, net | | 1.7 | | | 4.0 | | | 6.7 | |
| | | | | | |
Transaction related charges (1) | | 27.2 | | | 100.8 | | | 9.4 | |
Facility and other charge (2) | | 5.2 | | | 32.2 | | | 14.9 | |
| Restructuring and other charges, net | | $ | 50.8 | | | $ | 149.2 | | | $ | 54.5 | |
__________________________
(1) The year ended December 31, 2025 included the loss on the sale of the Insights business and the MSP Business, and acquisition-related compensation agreements. The year ended December 31, 2024 included the loss on sale of the Insights Business and acquisition-related compensation agreements. Refer to Note 21: Divestitures for additional information.
(2) Represents charges that are not included in one of the other classifications. The year ended December 31, 2025 primarily includes charges related to the sale of certain assets. The year ended December 31, 2024 primarily includes charges related to the exit of Spear, certain product lifecycle management activities and pension settlement costs. Refer to Note 21: Divestitures for additional information. The year ended December 31, 2023 primarily includes charges related to the exit of Spear.
The following table presents a rollforward of the severance portion of our restructuring obligations for the years ended December 31, 2025 and 2024:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Transformation Plan | | 2H 2024 Plan | | Q3 2023 Plan | | Other | | Total | | | |
| Balance as of December 31, 2023 | | $ | — | | | $ | — | | | $ | 6.0 | | | $ | 0.8 | | | $ | 6.8 | | | | |
| Charges, net of reversals | | — | | | 11.3 | | | 0.2 | | | 3.6 | | | 15.1 | | | | |
| Payments | | — | | | (6.1) | | | (5.7) | | | (3.7) | | | (15.5) | | | | |
| Foreign currency remeasurement | | — | | | — | | | (0.1) | | | (0.2) | | | (0.3) | | | | |
| Balance as of December 31, 2024 | | — | | | 5.2 | | | 0.4 | | | 0.5 | | | 6.1 | | | | |
| Charges, net of reversals | | 6.7 | | | (0.4) | | | 0.1 | | | 1.7 | | | 8.1 | | | | |
| Payments | | (2.2) | | | (4.9) | | | (0.4) | | | (2.1) | | | (9.6) | | | | |
| Foreign currency remeasurement | | — | | | 0.2 | | | — | | | — | | | 0.3 | | | | |
| Balance as of December 31, 2025 | | $ | 4.5 | | | $ | 0.2 | | | $ | — | | | $ | 0.1 | | | $ | 4.8 | | | | |
The severance portion of our restructuring obligations for each period presented was entirely recorded in accrued expenses and other current liabilities on our consolidated balance sheets. Refer to Note 12: Accrued Expenses and Other Current Liabilities.
6. Other, Net
The following table presents the components of other, net for the years ended December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
Currency remeasurement (loss)/gain on net monetary assets | $ | (4.9) | | | $ | 4.0 | | | $ | (20.2) | |
(Loss)/gain on foreign currency forward contracts | (2.5) | | | (2.6) | | | 4.2 | |
Gain/(loss) on commodity forward contracts | 28.1 | | | 3.5 | | | (2.8) | |
Gain/(loss) on debt financing transactions | 2.8 | | | (9.8) | | | (5.4) | |
Gain/(loss) on equity investments, net (1) | 1.9 | | | (14.0) | | | (0.7) | |
| Net periodic benefit cost, excluding service cost | (12.0) | | | (3.0) | | | (3.9) | |
| Other | 2.4 | | | 0.4 | | | 15.8 | |
| Other, net | $ | 15.8 | | | $ | (21.5) | | | $ | (13.0) | |
__________________________
(1) The year ended December 31, 2024, primarily includes a loss on equity investment that does not have a readily determinable fair value for which we use the measurement alternative prescribed in FASB Topic 321, Investments-Equity Securities. Refer to Note 18: Fair Value Measures for additional information.
7. Income Taxes
Refer to Note 2: Significant Accounting Policies for detailed discussion of the accounting policies related to income taxes. The Company is incorporated and domiciled in the United Kingdom; therefore, amounts presented as ‘domestic’ in the following disclosures refer to the U.K., while amounts labeled ‘foreign’ represent jurisdictions outside the U.K. Beginning in 2025, we adopted the enhanced income tax disclosure requirements pursuant to ASU 2023-09 prospectively. In addition, prior-year amounts have been restated to present the United Kingdom as ‘domestic,’ consistent with our jurisdiction of domicile. Previously, amounts labeled as ‘domestic’ reflected U.S. operations. This change in presentation has been applied retrospectively for comparability and does not affect total income tax expense or net income.
Income from continuing operations
Income/(loss) before taxes for the years ended December 31, 2025, 2024, and 2023 was categorized by jurisdiction as follows:
| | | | | | | | | | | | | | | | | |
| Domestic | | Foreign | | Total |
| 2025 | $ | 53.3 | | | $ | 70.1 | | | $ | 123.3 | |
| 2024 | $ | 35.0 | | | $ | (46.8) | | | $ | (11.8) | |
| 2023 | $ | 7.5 | | | $ | 10.3 | | | $ | 17.8 | |
Components of income tax expense (benefit)
Provision for income taxes for the years ended December 31, 2025, 2024, and 2023 comprised provisions for (or benefits from) income tax by jurisdiction as follows:
| | | | | | | | | | | | | | | | | |
| Domestic | | Foreign | | Total |
| 2025 | | | | | |
| Current | $ | 6.3 | | | $ | 86.0 | | | $ | 92.3 | |
| Deferred | 4.1 | | | (4.3) | | | (0.2) | |
| Total | $ | 10.4 | | | $ | 81.6 | | | $ | 92.0 | |
| 2024 | | | | | |
| Current | $ | 18.9 | | | $ | 74.2 | | | $ | 93.1 | |
| Deferred | (10.2) | | | (223.2) | | | (233.4) | |
| Total | $ | 8.7 | | | $ | (149.0) | | | $ | (140.3) | |
| 2023 | | | | | |
| Current | $ | 0.1 | | | $ | 75.8 | | | $ | 75.9 | |
| Deferred | (0.8) | | | (53.3) | | | (54.2) | |
| Total | $ | (0.7) | | | $ | 22.5 | | | $ | 21.8 | |
Cash taxes paid
The following table presents income taxes paid (net of refunds received) during the year ended December 31, 2025, disaggregated by jurisdiction.
| | | | | |
| 2025 |
China | $ | 58.1 | |
Netherlands | 19.8 | |
Germany - Federal | 6.8 | |
| |
Mexico | 7.6 | |
| |
| |
UK | 7.6 | |
Other foreign | 15.1 | |
Total | $ | 114.9 | |
Income taxes paid (net of refunds) were $92.6 million, and $95.5 million for the years ending December 31, 2024 and 2023, respectively.
Income taxes paid are presented on a cash basis and are net of refunds received during the year. Amounts paid to individual jurisdictions are separately presented when they equal or exceed 5% of total income taxes paid; all other jurisdictions are aggregated.
Income taxes paid include withholding taxes that are the legal obligation of the Company and are creditable or final in the applicable jurisdictions.
Effective tax rate reconciliation
The following table reconciles income tax expense (benefit) from continuing operations to the amount computed and the corresponding percentage of pre-tax income by applying the U.K. statutory income tax rate to pre-tax income for the year ended December 31, 2025:
| | | | | | | | |
| Amount | Percentage of Pre-tax Income |
Income tax at U.K. statutory rate (25.0%) | $ | 30.8 | | 25.0 | % |
| Foreign tax effects | | |
| United States reconciling items | | |
| US - state and local income taxes, net of federal income tax effect | 2.9 | | 2.4 | % |
| US - rate differential | 8.1 | | 6.6 | % |
| US - goodwill impairment | 46.4 | | 37.6 | % |
| | |
| | |
| US - other reconciling items | 6.6 | | 5.4 | % |
| Bulgaria reconciling items | | |
| Bulgaria - rate differential | (4.6) | | (3.7) | % |
| Bulgaria - other reconciling items | 1.7 | | 1.4 | % |
| China reconciling items | | |
| China - rate differential | (11.6) | | (9.4) | % |
| China - R&D superdeduction | (4.7) | | (3.8) | % |
| China - withholding taxes | 10.5 | | 8.5 | % |
| China - other reconciling items | 3.3 | | 2.7 | % |
| Malta reconciling items | | |
Malta - notional interest deduction | 14.2 | | 11.5 | % |
Malta - change in valuation allowance | (14.2) | | (11.5) | % |
Malta - other reconciling items | (2.1) | | (1.7) | % |
Mexico reconciling items | | |
Mexico - other reconciling items | 4.5 | | 3.6 | % |
| Netherlands reconciling items | | |
| Netherlands - change in valuation allowance | 13.8 | | 11.2 | % |
| Netherlands - other reconciling items | (0.5) | | (0.4) | % |
Switzerland reconciling items | | |
Switzerland - rate differential | (6.3) | | (5.1) | % |
Switzerland - other reconciling items | (0.1) | | (0.1) | % |
Foreign tax effects of other jurisdictions | 5.8 | | 4.7 | % |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Other adjustments | (3.6) | | (2.9) | % |
| Change in unrecognized tax benefits | (9.0) | | (7.3) | % |
| Total income tax expense/effective tax rate | $ | 92.0 | | 74.6 | % |
The following table reconciles income tax expense (benefit) from continuing operations to the amount computed by applying the U.K. statutory income tax rate to pre-tax income under the previous format for the years ended December 31, 2024 and 2023 as follows:
| | | | | | | | | | | | |
| | For the year ended December 31, 2024 | For the year ended December 31, 2023 | |
| | | | | | |
Tax computed at statutory rate of 25% for 2024 and 23.5% for 2023 | $ | (3.0) | | $ | 4.2 | | | | | |
Capital restructuring and dispositions | 40.6 | | (286.4) | | | | | |
| Valuation allowances | (180.0) | | 278.5 | | | | | |
Goodwill impairment | 31.5 | | 41.2 | | | | | |
| Foreign rate differential | (13.1) | | (17.7) | | | | | |
| Withholding taxes not creditable | 6.1 | | 14.1 | | | | | |
| Research and development incentives | (10.4) | | (9.0) | | | | | |
| U.S. state taxes, net of federal benefit | (23.4) | | (8.7) | | | | | |
| Unrealized foreign currency exchange losses/(gains), net | 2.3 | | 1.4 | | | | | |
| Reserve for tax exposure | (0.9) | | 1.1 | | | | | |
| Changes in tax laws or rates | (2.6) | | (0.3) | | | | | |
U.S. pension settlement | 9.9 | | — | | | | | |
| Nontaxable items and other | 2.7 | | 3.5 | | | | | |
| Provision for income taxes | $ | (140.3) | | $ | 21.8 | | | | | |
Foreign tax rate differential
We operate in multiple jurisdictions including but not limited to Bulgaria, China, Malaysia, Malta, the Netherlands, South Korea, the U.S., and the U.K. This can result in a foreign tax rate differential that may reflect a tax benefit or detriment. This differential can vary annually based upon the jurisdictional mix of earnings and changes in current and future enacted tax rates.
Certain of our subsidiaries are currently eligible, or have been eligible, for tax exemptions or reduced tax rates in their respective jurisdictions. The impact on current tax expense of the tax holidays and exemptions is included in the foreign tax rate differential disclosure, reconciling the statutory rate to our effective rate. The remeasurement of the deferred tax assets and liabilities is included in the change in tax laws or rates caption.
Withholding taxes not creditable
Withholding taxes may apply to intercompany interest, royalty, management fees, and certain payments to third parties. Such taxes are deducted if they cannot be credited against the recipient’s tax liability in its country of residence. We have also considered the withholding taxes associated with unremitted earnings and the recipient's ability to obtain a tax credit for such taxes. Earnings are not considered to be indefinitely reinvested in certain jurisdictions in which they were earned. In these jurisdictions we recognize a deferred tax liability on withholding and other taxes on intercompany payments including dividends.
Research and development incentives
Certain income of our U.K. subsidiaries is eligible for lower tax rates under the "patent box" regime, resulting in certain of our intellectual property income being taxed at a rate lower than the U.K. statutory tax rate. Qualified investments are eligible for a bonus deduction under China’s R&D super deduction regime. In the U.S., we benefit from R&D credit incentives.
Capital restructuring and dispositions
For the year ended December 31, 2024, the increase is primarily due to a strategy executed to secure the future deductibility of certain intellectual property rights. This unfavorable impact was partially offset by losses from the sale of the Insights business. Additionally, for the year ended December 31, 2023, the transfer of these intellectual property rights led to the recording of a deferred tax asset with a full valuation allowance.
Goodwill impairment
During the years ended December 31, 2025, 2024 and 2023, we incurred a non-cash impairment charge for goodwill that is generally nondeductible for tax purposes.
Deferred income tax assets and liabilities
The primary components of deferred income tax assets and liabilities as of December 31, 2025 and 2024 were as follows:
| | | | | | | | | | | |
| As of December 31, |
| 2025 | | 2024 |
| Deferred tax assets: | | | |
| Net operating loss, interest expense, and other carryforwards | $ | 550.0 | | | $ | 567.3 | |
| Prepaid and accrued expenses | 41.9 | | | 34.7 | |
| Intangible assets and goodwill | 80.6 | | | 104.0 | |
| Pension liability and other | 7.9 | | | 9.2 | |
| Property, plant and equipment | 15.9 | | | 13.0 | |
| Share-based compensation | 6.3 | | | 7.8 | |
| Inventories and related reserves | 18.2 | | | 21.9 | |
| Unrealized exchange loss | 3.8 | | | 3.8 | |
| | | |
| Total deferred tax assets | 724.8 | | | 761.8 | |
| Valuation allowance | (415.9) | | | (413.9) | |
| Net deferred tax asset | 308.8 | | | 347.8 | |
| Deferred tax liabilities: | | | |
| Intangible assets and goodwill | (222.8) | | | (240.1) | |
Tax on undistributed earnings of subsidiaries | (17.0) | | | (36.6) | |
| Operating lease right of use assets | (1.7) | | | (2.5) | |
| Property, plant and equipment | (15.3) | | | (14.5) | |
| Unrealized exchange gain | (1.8) | | | — | |
| Total deferred tax liabilities | (258.5) | | | (293.8) | |
| Net deferred tax liability | $ | 50.3 | | | $ | 54.1 | |
As of December 31, 2024, approximately $1.5 million of net deferred tax assets were associated with assets held for sale. Refer to Note 21: Divestitures for further information.
Valuation allowance and net operating loss carryforwards
We recognize deferred tax assets to the extent that we believe these assets are more likely than not to be realized. In measuring our deferred tax assets, we consider all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is needed for all or some portion of the deferred tax assets. Significant judgment is required in considering the relative impact of the negative and positive evidence, and weight given to each category of evidence is commensurate with the extent to which it can be objectively verified. The more negative evidence that exists, the more positive evidence is necessary, and the more difficult it is to support a conclusion that a valuation allowance is not needed. Additionally, we utilize the "more likely than not" criteria established in FASB ASC Topic 740 to determine whether the future tax benefit from the deferred tax assets should be recognized. As a result, we have established valuation allowances on the deferred tax assets in jurisdictions that have incurred net operating losses and in which it is more likely than not that such losses will not be utilized in the foreseeable future.
As of each reporting date, we consider new evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets. Our interest expense carryforwards in certain jurisdictions are subject to limitations. We consider these limitations in our assessment of positive and negative evidence. Our assessment of these limitations has resulted in the conclusion that a portion of our interest carryforwards is subject to a valuation allowance at both December 31, 2025 and December 31, 2024. We continually evaluate both the positive and negative evidence for these valuation allowances. We believe that there is a reasonable possibility that within the next 12 months, sufficient positive evidence may become available to allow a conclusion that a portion of the valuation allowance against these interest carryforwards will no longer be needed. Release of the valuation allowance would result in the recognition of this deferred tax asset and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are dependent on the level of profitability and likelihood of future utilization of this attributes that we are able to actually achieve.
For tax purposes, certain goodwill and indefinite-lived intangible assets are generally amortizable over 5 to 15 years. For book purposes, goodwill and indefinite-lived intangible assets are not amortized but are tested for impairment annually. The tax amortization of goodwill and indefinite-lived intangible assets will result in a taxable temporary difference, which will not reverse unless the related book goodwill or indefinite-lived intangible asset is impaired or written off. This liability may not be
used to support deductible temporary differences, such as net operating loss carryforwards, which may expire within a definite period.
The total valuation allowance increased $2.0 million in the year ended December 31, 2025 and decreased $155.6 million in the year 2024. During the year ended December 31, 2024, we executed a strategy to secure the future tax deductibility of certain intellectual property resulting in a $257.7 million reduction to the valuation allowance that was placed against this deferred tax asset in the year ended December 31, 2023. Subsequently reported tax benefits relating to the valuation allowance for deferred tax assets as of December 31, 2025 and 2024 have been allocated to income tax benefit recognized in the consolidated statements of operations.
As of December 31, 2025, we have U.S. federal net operating loss carryforwards of $506.2 million, of which $13.1 million will expire from 2031 to 2034, and $493.1 million do not expire. We have state net operating loss carryforwards with limited and unlimited lives. Our limited life state net operating losses will expire beginning in 2026. As of December 31, 2025, we have suspended interest expense carryforwards of $199.6 million in the U.S., $354.2 million in the Netherlands, and $137.8 million in the U.K., all of which have an unlimited life. We also have net operating loss carryforwards in various foreign jurisdictions of $459.1 million, which will begin to expire in 2026.
Unrecognized tax benefits
All uncertain tax positions have been classified in our balance sheet as noncurrent. A reconciliation of the amount of unrecognized tax benefits is as follows:
| | | | | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Balance at beginning of year | | $ | 180.2 | | | $ | 187.2 | | | $ | 224.6 | |
| Increases related to current year tax positions | | 1.0 | | | 2.1 | | | 3.3 | |
| Increases related to prior year tax positions | | 0.1 | | | 1.0 | | | 1.2 | |
| Decreases related to business combinations and dispositions | | — | | | (0.1) | | | — | |
| Decreases related to settlements with tax authorities | | — | | | — | | | (0.4) | |
| Decreases related to prior year tax positions | | (1.8) | | | (9.6) | | | (41.2) | |
| Decreases related to lapse of applicable statute of limitations | | (5.9) | | | — | | | (0.7) | |
| (Decreases)/increases related to foreign currency exchange rates | | 0.3 | | | (0.4) | | | 0.4 | |
| Balance at end of year | | $ | 173.9 | | | $ | 180.2 | | | $ | 187.2 | |
We recognize interest and penalties related to unrecognized tax benefits in the consolidated statements of operations and the consolidated balance sheets. The following table presents the expense/(income) related to such interest and penalties recognized in the consolidated statements of operations during the years ended December 31, 2025, 2024, and 2023, and the amount of interest and penalties recorded on the consolidated balance sheets as of December 31, 2025 and 2024:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Statements of Operations | | Balance Sheets |
| For the year ended December 31, | | As of December 31, |
| (In millions) | 2025 | | 2024 | | 2023 | | 2025 | | 2024 |
| Interest | $ | (2.3) | | | $ | 1.4 | | | $ | 0.3 | | | $ | 1.5 | | | $ | 3.9 | |
| Penalties | $ | 0.0 | | | $ | (0.1) | | | $ | 0.0 | | | $ | 0.4 | | | $ | 0.4 | |
The amount of unrecognized tax benefits as of December 31, 2025 that if recognized would impact our effective tax rate is $130.6 million.
The Company is subject to income tax examinations by tax authorities in jurisdictions in which it operates. In the United Kingdom, tax years 2022 through 2025 remain open to examination under HMRC's normal four-year assessment time limit measured from the end of the relevant accounting period (absent extended-period triggers). Tax years in other significant jurisdictions remain open to examination as follows: China and Switzerland (2023 through 2025), the Netherlands (2021 through 2025), and the United States (2022 through 2025). Certain U.S. state and local jurisdictions remain open for similar periods; these jurisdictions are not individually material to the Company.
On December 15, 2022, the European Union ("EU") Member States formally adopted the EU's Pillar Two Directive, which generally establishes a minimum effective tax rate of 15% on a jurisdictional basis. The Directive became effective for the Company for the fiscal years beginning on or after January 1, 2024.
The Company has evaluated the impact of the Pillar Two rules, including enacted legislation and administrative guidance in the jurisdictions in which it operates, and continues to monitor further developments. Based on the Company’s analysis to date, the adoption of Pillar Two has not had a material impact on the Company’s consolidated financial statements or related disclosures for the years ended December 31, 2025 and 2024. The Company will continue to assess the impact of Pillar Two as additional guidance is issued and as jurisdictions finalize or amend their implementing legislation.
In July 2025, the U.S. enacted Public Law 119-21 (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) (commonly referred to as the “One Big Beautiful Bill”). The legislation includes multiple effective dates, with certain provisions retroactive to January 1, 2025, and others becoming effective through 2027.
The Company is continuing to evaluate the provisions of the legislation, including available elections, and the related impacts on its consolidated financial statements and disclosures. While the Company does not expect the adoption of Public Law 119-21 to have a material adverse impact on its consolidated financial statements, the evaluation of certain provisions remains ongoing.
Indemnifications
We have various indemnification provisions in place with parties including Honeywell (sellers of First Technology Automotive and Special Products), the former shareholders of Elastic M2M, Inc., Sendyne Corp., SmartWitness Holdings, Inc., Xirgo Technologies Intermediate Holdings, LLC and Xirgo Holdings, Inc., whereby such provisions provide for the reimbursement of future tax liabilities paid by us that relate to the pre-acquisition periods of the acquired businesses.
8. Net Income/(Loss) per Share
Basic and diluted net income/(loss) per share are calculated by dividing net income/(loss) by the number of basic and diluted weighted-average ordinary shares outstanding during the period. For the years ended December 31, 2025, 2024, and 2023, the weighted-average ordinary shares outstanding used to calculate basic and diluted net income/(loss) per share were as follows:
| | | | | | | | | | | | | | | | | |
| For the year ended December 31, |
(In millions) | 2025 | | 2024 | | 2023 |
| Basic weighted-average ordinary shares outstanding | 146.5 | | | 150.4 | | | 152.1 | |
Dilutive effect of stock options | — | | | — | | | — | |
Dilutive effect of unvested restricted securities | 0.6 | | | 0.3 | | | — | |
| Diluted weighted-average ordinary shares outstanding | 147.1 | | | 150.7 | | | 152.1 | |
Net income/(loss) and net income/(loss) per share are presented in the consolidated statements of operations.
Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because either they would have had an anti-dilutive effect on net income/(loss) per share or they related to equity awards that were contingently issuable for which the contingency had not been satisfied. Refer to Note 4: Share-Based Compensation for additional information related to our equity awards. These potential ordinary shares are as follows:
| | | | | | | | | | | | | | | | | |
| For the year ended December 31, |
(In millions) | 2025 | | 2024 | | 2023 |
| Anti-dilutive shares excluded | 1.0 | | | 1.3 | | | 2.9 | |
| Contingently issuable shares excluded | 0.9 | | | 0.9 | | | 1.2 | |
9. Inventories
The following table presents the components of inventories as of December 31, 2025 and 2024:
| | | | | | | | | | | |
| As of December 31, |
| 2025 | | 2024 |
| Finished goods | $ | 196.6 | | | $ | 193.2 | |
| Work-in-process | 144.8 | | | 134.4 | |
| Raw materials | 276.4 | | | 286.9 | |
| Inventories | $ | 617.8 | | | $ | 614.5 | |
Refer to Note 2: Significant Accounting Policies for a discussion of our accounting policies related to inventories.
10. Property, Plant and Equipment, Net
PP&E, net as of December 31, 2025 and 2024 consisted of the following:
| | | | | | | | | | | | | | |
| | As of December 31, |
| | 2025 | | 2024 |
| Land | | $ | 14.7 | | | $ | 15.7 | |
| Buildings and improvements | | 344.4 | | | 266.3 | |
| Machinery and equipment | | 1,909.1 | | | 1,831.1 | |
| Total property, plant and equipment | | 2,268.3 | | | 2,113.1 | |
| Accumulated depreciation | | (1,491.8) | | | (1,291.4) | |
| Property, plant and equipment, net | | $ | 776.5 | | | $ | 821.7 | |
Depreciation expense for PP&E, including amortization of leasehold improvements and depreciation of assets under finance leases, totaled $176.2 million, $167.1 million, and $133.1 million for the years ended December 31, 2025, 2024, and 2023, respectively.
Refer to Note 2: Significant Accounting Policies for a discussion of our accounting policies related to PP&E, net.
11. Goodwill and Other Intangible Assets, Net
Goodwill
The following table presents the changes in net goodwill by segment for the years ended December 31, 2025 and 2024.
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | Automotive (1) | | Industrials (1) | | Aerospace, Defense, and Commercial Equipment (1) | | | | Total |
| Balance as of December 31, 2023 | $ | 1,728.5 | | | $ | 1,149.8 | | | $ | 664.5 | | | | | $ | 3,542.8 | |
Divestiture | (7.2) | | | — | | | (1.6) | | | | | (8.8) | |
| | | | | | | | | |
Goodwill impairment charge (2) | — | | | (150.1) | | | — | | | | | (150.1) | |
Foreign currency translation effect | (0.1) | | | — | | | — | | | | | (0.1) | |
Goodwill reallocation | 21.0 | | | — | | | (21.0) | | | | | — | |
| Balance as of December 31, 2024 | 1,742.2 | | | 999.7 | | | 641.9 | | | | | 3,383.8 | |
| | | | | | | | | |
Goodwill impairment charge (2) | — | | | (225.7) | | | — | | | | | (225.7) | |
Foreign currency translation effect | 0.1 | | | — | | | — | | | | | 0.1 | |
| | | | | | | | | |
| Balance as of December 31, 2025 | $ | 1,742.3 | | | $ | 774.0 | | | $ | 641.9 | | | | | $ | 3,158.2 | |
__________________________
(1) Effective December 31, 2025, we reorganized our reporting units into new reportable segments. Refer to Note 20: Segment Reporting for additional information. There was no accumulated goodwill impairment related to either the Automotive or the Aerospace, Defense, and Commercial Equipment reportable segments as of December 31, 2025. 2024. and 2023. Accumulated goodwill impairment related to the Industrials reportable segment was $394.3 million, $168.6 million, and $18.5 million as of December 31, 2025, 2024, and 2023. In the fourth quarter of 2023, we recorded a $321.7 million impairment charge in connection with our former Insights reporting unit which was not aggregated into a reportable segment.
(2) In the third quarters of 2025 and 2024, we determined that our Dynapower reporting unit was impaired and we recorded non-cash impairment charges of $225.7 million and $150.1 million, respectively. Refer to additional information under the heading Reporting Units below.
Acquisitions and Divestitures
Goodwill attributed to acquisitions reflects our allocation of purchase price to the estimated fair value of certain assets acquired and liabilities assumed. Net assets acquired are comprised of tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values. We apply estimates and assumptions to determine the fair value of the intangible assets and of any contingent consideration obligations. Critical estimates in valuing purchased technology, customer relationships, and other identifiable intangible assets include future cash flows that we expect to generate from the acquired assets. In addition, we estimate the economic lives of these identified intangible assets and these lives are used to calculate
amortization expense. Goodwill has been included in our segments based on a methodology using anticipated future earnings of the components of business.
Reporting Units
In the third quarter of 2025, impairment indicators were identified that suggested the carrying value of the Dynapower reporting unit could exceed its fair values. The primary indicators of impairment were a lower outlook within certain markets that the reporting unit operates in following recent tax legislation being enacted, and the strategic shift to focus on other markets. This revised outlook led to downward revisions of forecasted future cash flows. We evaluated the goodwill of the Dynapower reporting unit for impairment using a combination of a market-based valuation method and an income approach that discounts forecasted cash flows. As these assumptions were largely unobservable, the estimated fair values fall within Level 3 of the fair value hierarchy. A change in our cash flow forecast or the discount rate used would result in an increase or decrease in our calculated fair value. We determined that our Dynapower reporting unit was impaired, and in the third quarter of 2025, we recorded a $225.7 million non-cash impairment charge. If Dynapower does not achieve the forecasted cash flows, there is a possibility that additional impairments of the remaining $4.1 million of goodwill may be recognized in the future.
As of October 1, 2025, we had six reporting units, Automotive, Commercial Equipment, Industrial Solutions, Aerospace, Aftermarket, and Dynapower. There have been no subsequent changes to our reporting units as of December 31, 2025.
We evaluated our goodwill for impairment as of October 1, 2025, using a qualitative analysis. A qualitative analysis is performed by evaluating events and circumstances that most affect the fair value of each reporting unit, including macroeconomic conditions, market conditions, industry trends, cost factors, financial performance, and other relevant qualitative factors. The results of the qualitative analyses did not indicate a need to perform quantitative analysis, as we determined that it is more likely than not that the fair value of each of our reporting units exceeded their respective carrying values. No events or circumstances occurred between October 1, 2025 and December 31, 2025 that would more likely than not reduce the fair values of the reporting units below their carrying amounts.
We consider a combination of quantitative and qualitative factors to determine whether a reporting unit is at risk of failing the goodwill impairment test, including: the timing of our most recent quantitative impairment tests and the relative amount by which a reporting unit’s fair value exceeded its then carrying value, the inputs and assumptions underlying our valuation models and the sensitivity of our fair value measurements to those inputs and assumptions, the impact that adverse economic or market conditions may have on the degree of uncertainty inherent in our long-term operating forecasts, and changes in the carrying value of a reporting unit’s net assets from the time of our most recent goodwill impairment test. We also consider the impact of recent impairments in our expectations of the reporting units, such as the Dynapower reporting unit, and how actual performance against the forecasted performance, might put pressure on the reporting unit's fair value over carrying value in the short term.
Indefinite-Lived Intangible Assets
We own the Klixon® and Airpax® tradenames, which are indefinite-lived intangible assets as they have been in continuous use since 1927 and 1948, respectively, and we have no plans to discontinue using either of them. We evaluated our indefinite-lived intangible assets for impairment as of October 1, 2025 and 2024 using a qualitative analysis and no impairment was identified. As of each of December 31, 2025 and 2024, we have $59.1 million and $9.4 million for the Klixon® and Airpax® tradenames, respectively, on our consolidated balance sheets.
Definite-Lived Intangible Assets
The following tables outline the components of definite-lived intangible assets as of December 31, 2025 and 2024:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | As of December 31, 2025 |
Weighted- Average Life (years) | | Gross Carrying Amount | | Accumulated Amortization | | Accumulated Impairment | | Foreign Currency Translation Effect | | Net Carrying Value |
Completed technologies | 10 | | $ | 893.0 | | | $ | (769.6) | | | $ | (2.4) | | | $ | 0.2 | | | $ | 121.2 | |
Customer relationships | 11 | | 1,863.9 | | | (1,691.9) | | | (12.2) | | | — | | | 159.8 | |
Backlog | 0 | | 15.5 | | | (15.5) | | | — | | | — | | | — | |
Tradenames | 14 | | 96.8 | | | (39.3) | | | — | | | — | | | 57.5 | |
| Capitalized software and other | 5 | | 77.0 | | | (72.4) | | | — | | | — | | | 4.6 | |
| Total | 11 | | $ | 2,946.2 | | | $ | (2,588.7) | | | $ | (14.6) | | | $ | 0.2 | | | $ | 343.1 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | As of December 31, 2024 |
Weighted- Average Life (years) | | Gross Carrying Amount | | Accumulated Amortization | | Accumulated Impairment | | Foreign Currency Translation Effect | | Net Carrying Value |
Completed technologies (1)(2) | 11 | | $ | 924.5 | | | $ | (767.3) | | | $ | (2.4) | | | $ | (0.1) | | | $ | 154.7 | |
Customer relationships (1)(2) | 11 | | 1,883.8 | | | (1,676.0) | | | (12.2) | | | — | | | 195.6 | |
| Backlog | 1 | | 15.5 | | | (13.3) | | | — | | | — | | | 2.2 | |
Tradenames (1)(2) | 15 | | 99.9 | | | (35.6) | | | — | | | — | | | 64.3 | |
| | | | | | | | | | | |
| Capitalized software and other | 6 | | 76.7 | | | (69.1) | | | — | | | — | | | 7.6 | |
| Total | 12 | | $ | 3,000.4 | | | $ | (2,561.3) | | | $ | (14.6) | | | $ | (0.1) | | | $ | 424.4 | |
__________________________
(1) During the year ended December 31, 2024, we sold the Insights Business, which included approximately $58.7 million, $184.3 million and $4.0 million of net assets for completed technologies, customer relationships, and tradenames, respectively.
(2) During the year ended December 31, 2024, we completed our exit of the Spear businesses triggering the acceleration of amortization totaling $7.1 million, $2.1 million and $0.5 million for completed technologies, customer relationships and trademarks, respectively.
The following table outlines amortization of definite-lived intangible assets for the years ended December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| For the year ended December 31, |
| 2025 | | 2024 | | 2023 |
| Acquisition-related definite-lived intangible assets | $ | 76.9 | | | $ | 140.6 | | | $ | 167.7 | |
| Capitalized software | 3.3 | | | 5.1 | | | 6.2 | |
| Amortization of intangible assets | $ | 80.2 | | | $ | 145.7 | | | $ | 173.9 | |
The table below presents estimated amortization of definite-lived intangible assets for each of the next five years:
| | | | | |
| For the year ended December 31, | |
| 2026 | $ | 62.5 | |
| 2027 | $ | 54.6 | |
| 2028 | $ | 45.4 | |
| 2029 | $ | 36.3 | |
| 2030 | $ | 31.1 | |
12. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities as of December 31, 2025 and 2024 consisted of the following:
| | | | | | | | | | | |
| As of December 31, |
| 2025 | | 2024 |
| Accrued compensation and benefits | $ | 96.8 | | | $ | 71.2 | |
| Accrued interest | 48.6 | | | 55.2 | |
| Foreign currency and commodity forward contracts | 16.0 | | | 22.7 | |
| Current portion of operating lease liabilities | 15.7 | | | 13.1 | |
| Accrued severance | 4.8 | | | 6.1 | |
| Current portion of pension and post-retirement benefit obligations | 10.2 | | | 2.3 | |
| Other accrued expenses and current liabilities | 151.0 | | | 146.7 | |
| Accrued expenses and other current liabilities | $ | 343.1 | | | $ | 317.3 | |
13. Pension and Other Post-Retirement Benefits
We provide various pension and other post-retirement benefit plans for current and former employees, including defined benefit, defined contribution, and retiree healthcare benefit plans. Refer to Note 2: Significant Accounting Policies for discussion of our accounting policies related to our pension and other post-retirement benefit plans.
U.S. Benefit Plans
The principal retirement plans in the U.S. is a defined contribution plan. In addition, we provide post-retirement medical coverage and non-qualified benefits to certain employees. During the year ended December 31, 2024, we terminated the defined benefit pension plan.
Non-U.S. Benefit Plans
Retirement coverage for non-U.S. employees is provided through separate defined benefit and defined contribution plans. Retirement benefits are generally based on an employee’s years of service and compensation. Funding requirements are determined on an individual country and plan basis and are subject to local country practices and market circumstances. We do not expect to make material contributions to the non-U.S. defined benefit plans during 2026.
Impact on Financial Statements
The total net periodic benefit cost associated with our defined benefit and retiree healthcare plans for the years ended December 31, 2025, 2024, and 2023 was $16.0 million, $12.5 million, and $7.9 million, respectively. Components of net periodic benefit cost other than service cost are generally presented in other, net in the consolidated statements of operations. Refer to Note 6: Other, Net.
The following table presents changes in the benefit obligation and plan assets for our defined benefit and other post-retirement benefit plans in total for the years ended December 31, 2025 and 2024:
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | For the year ended December 31, | | |
| | | | | | 2025 | | | | 2024 | | |
| | | | | | | | | |
| | | | | | | | | | | | | |
| Change in benefit obligation: | | | | | | | | | | | | | |
| Beginning balance | | | | | $ | 65.4 | | | | | | | $ | 87.7 | | | |
| Service cost | | | | | 3.3 | | | | | | | 3.4 | | | |
| Interest cost | | | | | 3.2 | | | | | | | 3.3 | | | |
| Plan participants’ contributions | | | | | 0.4 | | | | | | | 0.5 | | | |
| | | | | | | | | | | | | |
Actuarial loss/(gain) | | | | | (0.5) | | | | | | | (0.1) | | | |
Curtailment loss | | | | | 9.8 | | | | | | | — | | | |
| Benefits paid | | | | | (4.8) | | | | | | | (21.6) | | | |
| | | | | | | | | | | | | |
| Divestiture | | | | | (2.7) | | | | | | | — | | | |
| Foreign currency remeasurement | | | | | 4.9 | | | | | | | (7.8) | | | |
| Ending balance | | | | | $ | 79.1 | | | | | | | $ | 65.4 | | | |
| Change in plan assets: | | | | | | | | | | | | | |
| Beginning balance | | | | | $ | 34.8 | | | | | | | $ | 46.9 | | | |
| Actual return on plan assets | | | | | 2.0 | | | | | | | 2.0 | | | |
| Employer contributions | | | | | 3.6 | | | | | | | 10.5 | | | |
| Plan participants’ contributions | | | | | 0.4 | | | | | | | 0.5 | | | |
| Benefits paid | | | | | (4.8) | | | | | | | (21.6) | | | |
| | | | | | | | | | | | | |
| Foreign currency remeasurement | | | | | 1.3 | | | | | | | (3.3) | | | |
| Ending balance | | | | | $ | 37.3 | | | | | | | $ | 34.8 | | | |
| Funded status at end of year | | | | | $ | (41.8) | | | | | | | $ | (30.6) | | | |
| Accumulated benefit obligation at end of year | | | | | $ | 67.6 | | | | | | | $ | 55.9 | | | |
During 2025, the Company recorded a charge of $9.8 million primarily related to workforce reduction in Mexico. Curtailment charges are included in other, net.
Assumptions and Investment Policies
Weighted-average assumptions used to calculate the projected benefit obligations of our defined benefit and retiree healthcare benefit plans as of December 31, 2025 and 2024 are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | |
| As of December 31, | |
| | 2025 | | 2024 | |
| | Defined Benefit | | Retiree Healthcare | | Defined Benefit | | Retiree Healthcare | |
| U.S. assumed discount rate | NA | | 4.90 | % | | 4.65 | % | | 5.35 | % | |
| Non-U.S. assumed discount rate | 6.25 | % | | NA | | 5.22 | % | | NA | |
| Non-U.S. average long-term pay progression | 3.91 | % | | NA | | 3.41 | % | | NA | |
Weighted-average assumptions used to calculate the net periodic benefit cost of our defined benefit and retiree healthcare benefit plans for the years ended December 31, 2025, 2024, and 2023 are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 | |
| | Defined Benefit | | Retiree Healthcare | | Defined Benefit | | Retiree Healthcare | | Defined Benefit | | Retiree Healthcare | |
| U.S. assumed discount rate | NA | | 5.35 | % | | 4.85 | % | | 4.85 | % | | 5.10 | % | | 5.15 | % | |
| Non-U.S. assumed discount rate | 10.16 | % | | NA | | 7.90 | % | | NA | | 7.14 | % | | NA | |
| U.S. average long-term rate of return on plan assets | NA | | NA | | NA | | NA | | 4.36 | % | | NA | |
| Non-U.S. average long-term rate of return on plan assets | 2.57 | % | | NA | | 2.50 | % | | NA | | 2.73 | % | | NA | |
| Non-U.S. average long-term pay progression | 4.96 | % | | NA | | 5.06 | % | | NA | | 4.96 | % | | NA | |
Plan Assets
We hold material assets for our defined benefit plan in Japan. Information about the assets for this plan is detailed below. Refer to Note 18: Fair Value Measures for additional information related to the levels of the fair value hierarchy in accordance with FASB ASC Topic 820.
Japan plan assets
The target asset allocation of the Japan defined benefit plan is 50% fixed income securities, cash, and cash equivalents and 50% equity securities, with allowance for a 40% deviation in either direction. We, along with the trustee of the plan's assets, minimize investment risk by thoroughly assessing potential investments based on indicators of historical returns and current credit ratings. Additionally, investments are diversified by type and geography.
The total fair value of our Japan plan assets as of December 31, 2025 and 2024 was $28.7 million and $26.5 million, respectively, which included $10.9 million and $9.2 million, respectively, of equity securities, $8.3 million and $7.3 million, respectively, of fixed income securities, and $7.4 million and $8.1 million, respectively, of cash and cash equivalents.
All fair value measures presented above are categorized in Level 1 of the fair value hierarchy, with the exception of non-U.S. fixed income securities of $2.0 million, and alternative risk managed balance of $2.0 million as of December 31, 2025, which are categorized as Level 2. The fair values of equity and fixed income securities are based on publicly-quoted closing stock and bond values on the last business day of the year.
Permitted asset classes include equity securities that are traded on the official stock exchange(s) of the respective countries, fixed income securities with certain credit ratings, cash, and cash equivalents.
14. Debt
Our long-term debt, net and finance lease obligations as of December 31, 2025 and 2024 consisted of the following:
| | | | | | | | | | | | | | | | | |
| | | As of December 31, |
| Maturity Date | | 2025 | | 2024 |
| | | | | |
| | | | | |
| | | | | |
4.0% Senior Notes (1) | April 15, 2029 | | 646.0 | | | 1,000.0 | |
4.375% Senior Notes | February 15, 2030 | | 450.0 | | | 450.0 | |
5.875% Senior Notes | September 1, 2030 | | 500.0 | | | 500.0 | |
3.75% Senior Notes | February 15, 2031 | | 750.0 | | | 750.0 | |
| | | | | |
| | | | | |
6.625% Senior Notes | July 15, 2032 | | 500.0 | | | 500.0 | |
Plus: debt premium, net of discount | | | 0.5 | | | 1.0 | |
| Less: deferred financing costs | | | (17.9) | | | (24.9) | |
| | | | | |
| Long-term debt, net | | | $ | 2,828.6 | | | $ | 3,176.1 | |
Finance lease obligations | | | $ | 21.2 | | | $ | 23.4 | |
| Less: current portion | | | (2.3) | | | (2.4) | |
Finance lease obligations, less current portion | | | $ | 18.9 | | | $ | 21.0 | |
_______________________________
(1) In November 2025, we purchased $354.0 million in aggregate principal amount of the 4.0% Senior Notes that were validly tendered in a cash tender offer that we commenced in October 2025. We paid $350.0 million in cash in the aggregate for such purchase.
Fiscal year 2025 transactions
In September 2025, certain of our indirect, wholly-owned subsidiaries, including Sensata Technologies, Inc. ("STI"), Sensata Technologies Intermediate Holding B.V., and Sensata Technologies B.V. (“STBV”), entered into an amendment (the “Fourteenth Amendment”) to our credit agreement, dated as of May 12, 2011 (as amended, supplemented, waived, or otherwise modified, the “Credit Agreement”).
Among other changes to the Credit Agreement, the Fourteenth Amendment (i) reduced the total amount of the revolving credit facility commitments of the lenders from $750.0 million to $650.0 million, (ii) extended the maturity date of the revolving credit facility to September 24, 2030, and (iii) modified certain of the operational and restrictive covenants and other terms and conditions of the Credit Agreement to provide us increased flexibility and permissions thereunder.
In October 2025, STBV and STI, announced the commencement of a cash tender offer for up to $350.0 million of aggregate cash consideration payable for the 4.0% Senior Notes, the 4.375% Senior Notes due 2030 (the "4.375% Senior Notes"), and the 5.875% Senior Notes due 2030 (the "5.875% Senior Notes"). In November 2025, we purchased $354.0 million in aggregate principal amount of the 4.0% Senior Notes that were validly tendered in connection with that tender offer. We paid $350.0 million in cash in the aggregate for such purchase. We did not purchase any 4.375% Senior Notes or 5.875% Senior Notes in these tender offers.
Secured Credit Facility
The Credit Agreement provides for a senior secured credit facility, consisting of a revolving credit facility (the "Revolving Credit Facility"), and incremental availability under which additional secured credit facilities could be issued under certain circumstances. All obligations under the senior secured credit facility are unconditionally guaranteed by certain of our subsidiaries and secured by substantially all present and future property and assets of STBV and its guarantor subsidiaries.
In September 2025, we entered into the Fourteenth Amendment, which: (i) reduced the total amount of the Revolving Credit Facility commitments of the lenders from $750.0 million to $650.0 million, (ii) extended the maturity date of the Revolving Credit Facility to September 24, 2030, and (iii) modified certain of the operational and restrictive covenants and other terms and conditions of the Credit Agreement to provide us increased flexibility and permissions thereunder.
Borrowings under the Revolving Credit Facility may, at our option, be maintained from time to time as Base Rate loans, Term SOFR loans, EURIBOR loans, or Daily Simple SONIA loans (each as defined in the Credit Agreement), with each representing a different determination of interest rates. The interest rate margins and letter of credit fees under the Revolving Credit Facility are as follows (each depending on our senior secured net leverage ratio): (i) the interest rate margin for Base Rate loans range from 0.00% to 0.50%; (ii) the interest rate margins for Term SOFR, EURIBOR loans, and Daily Simple SONIA loans range from 1.00% to 1.50%; and (iii) the letter of credit fees range from 0.875% to 1.375%.
We are required to pay to our revolving credit lenders, on a quarterly basis, a commitment fee on the unused portion of the Revolving Credit Facility. The commitment fee ranges from 0.125% to 0.250%, depending on our senior secured net leverage ratios.
As of December 31, 2025, there was $645.8 million available under the Revolving Credit Facility, net of $4.2 million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of December 31, 2025, no amounts had been drawn against these outstanding letters of credit. Loans under the Revolving Credit Facility may be borrowed, repaid, and re-borrowed and may be used to fund our working capital needs and for other general corporate purposes.
Senior Notes
We have various tranches of senior unsecured notes outstanding as of December 31, 2025. Information regarding these senior notes (together, the "Senior Notes") is included in the following table. The Senior Notes were issued under the Senior Notes Indentures among the issuers listed in the table below, The Bank of New York Mellon, as trustee, and our guarantor subsidiaries named in the respective senior notes indentures (the "Senior Notes Indentures").
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | 4.0% Senior Notes (1) | | 4.375% Senior Notes | | 5.875% Senior Notes | | 3.75% Senior Notes | | 6.625% Senior Notes (2) |
Aggregate outstanding principal amount | | | | | | | $646.0 | | $450.0 | | $500.0 | | $750.0 | | $500.0 |
| Interest rate | | | | | | | 4.000% | | 4.375% | | 5.875% | | 3.750% | | 6.625% |
| Issue price | | | | | | | Various | | 100.000% | | 100.000% | | 100.000% | | 100.000% |
| Issuer | | | | | | | STBV | | STI | | STBV | | STI | | STI |
| Issue date | | | | | | | Various | | September 2019 | | August 2022 | | August 2020 | | June 2024 |
| Interest due | | | | | | | April 15 | | February 15 | | September 1 | | February 15 | | January 15 |
| Interest due | | | | | | | October 15 | | August 15 | | March 1 | | August 15 | | July 15 |
| | | | | | | | | | | | | | | |
__________________________
(1) In November 2025, we purchased $354.0 million in aggregate principal amount of the 4.0% Senior Notes") that were validly tendered in a cash tender offer that we commenced in October 2025. We paid $350.0 million in cash in the aggregate for such purchase. On March 29, 2021, we issued $750.0 million of 4.0% Senior Notes that were priced at 100.00%. On April 8, 2021, we issued $250.0 million of 4.0% Senior Notes that were priced at 100.75%.
(2) On June 6, 2024, we issued $500.0 million of 6.625% Senior Notes that were priced at 100.00%.
Redemption - General
Upon the occurrence of certain specific change in control events, we will be required to offer to repurchase the Senior Notes at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.
If changes in certain tax laws or treaties, or any change in the official application, administration, or interpretation thereof, of any relevant taxing jurisdiction become effective that would impose withholding taxes or other deductions on the payments of any of the Senior Notes or the guarantees thereof, we may, at our option, redeem the relevant Senior Notes in whole but not in part, at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, premium, if any, and all additional amounts (as described in the relevant Senior Notes Indenture), if any, then due and which will become due on the date of redemption.
Redemption - 4.0% Senior Notes
On or after April 15, 2024, STBV may optionally redeem the 4.0% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date:
| | | | | |
| Period beginning April 15, | Price |
| 2024 | 102.000 | % |
| 2025 | 101.000 | % |
| 2026 and thereafter | 100.000 | % |
In addition, at any time prior to April 15, 2024, STBV may redeem up to 40% of the principal amount of the outstanding 4.0% Senior Notes (including additional 4.0% Senior Notes, if any, that may be issued after March 29, 2021) with the net cash proceeds of certain equity offerings at a redemption price (expressed as a percentage of principal amount) of 104.00%, plus
accrued and unpaid interest, if any, up to but excluding the redemption date, provided that at least 60% of the aggregate principal amount of the 4.0% Senior Notes (including additional 4.0% Senior Notes, if any) remains outstanding immediately after each such redemption.
Redemption - 4.375% Senior Notes
At any time, and from time to time, prior to November 15, 2029, STI may redeem the 4.375% Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 4.375% Senior Notes being redeemed, plus a “make whole” premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. On or after such date, STI may optionally redeem the 4.375% Senior Notes, in whole or in part, at a price equal to 100.000 of principal amount, plus accrued and unpaid interest, if any, up to but excluding the redemption date.
Redemption - 5.875% Senior Notes
At any time on or after September 1, 2025, STBV may redeem the 5.875% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date:
| | | | | |
| Period beginning September 1, | Price |
| 2025 | 102.398 | % |
| 2026 | 101.469 | % |
| 2027 and thereafter | 100.000 | % |
In addition, at any time prior to September 1, 2025, STBV may redeem up to 40% of the principal amount of the outstanding 5.875% Senior Notes (including additional 5.875% Senior Notes, if any) with the net cash proceeds of certain equity offerings at a redemption price (expressed as a percentage of principal amount) of 105.875%, plus accrued and unpaid interest, if any, up to but excluding the redemption date, provided that at least 60% of the aggregate principal amount of the 5.875% Senior Notes (including additional 5.875% Senior Notes, if any) remains outstanding immediately after each such redemption.
Redemption - 3.75% Senior Notes
At any time, and from time to time, prior to February 15, 2026, STI may redeem the 3.75% Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 3.75% Senior Notes being redeemed, plus a “make whole” premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. On or after such date, we may optionally redeem the 3.75% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date:
| | | | | |
|
| Period beginning February 15, | Price |
| 2026 | 101.875 | % |
| 2027 | 100.938 | % |
| 2028 and thereafter | 100.000 | % |
Redemption - 6.625% Senior Notes
At any time, and from time to time, prior to July 15, 2027, STI may redeem the 6.625% Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 6.625% Senior Notes being redeemed, plus a “make whole” premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. On or after such date, STI may optionally redeem the 6.625% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date:
| | | | | |
| Period beginning July 15, | Price |
| 2027 | 103.313 | % |
| 2028 | 101.656 | % |
| 2029 and thereafter | 100.000 | % |
In addition, at any time prior to July 15, 2027, STI may redeem up to 40% of the principal amount of the outstanding 6.625% Senior Notes (including additional 6.625% Senior Notes, if any) with the net cash proceeds of certain equity offerings at a redemption price (expressed as a percentage of principal amount) of 106.625%, plus accrued and unpaid interest, if any, to, but
excluding, the redemption date, provided that at least 60% of the aggregate principal amount of the 6.625% Senior Notes (including additional 6.625% Senior Notes, if any) remains outstanding immediately after each such redemption.
Guarantees
The obligations of the issuers of the Senior Notes are guaranteed by STBV (other than with respect to the Senior Notes of which it is the issuer), STI (other than with respect to the Senior Notes of which it is the issuer) and all of STBV's other subsidiaries (excluding the company that is the issuer of the relevant Senior Notes) that guarantee the obligations of STI under the Credit Agreement (after giving effect to the release of guarantees pursuant to the Thirteenth Amendment discussed below).
In August 2023, we entered into an amendment to the Credit Agreement (the "Thirteenth Amendment"), to, among other things, release all of the non-U.S. subsidiaries of STBV that had previously been guarantors and securing parties under the Credit Agreement from all of their remaining obligations as guarantors and securing parties under the Credit Agreement, subject to an obligation to reinstate the guarantees under certain conditions. These subsidiaries were also released from their guaranty obligations with respect to the 4.0% Senior Notes, the 5.875% Senior Notes, the 4.375% Senior Notes, and the 3.75% Senior Notes, in each case in accordance with the terms of the relevant Senior Notes Indenture pursuant to which such senior notes were issued.
Events of Default
The Senior Notes Indentures provide for events of default that include, among others, nonpayment of principal or interest when due, breach of covenants or other provisions in the relevant Senior Notes Indenture, defaults in payment of certain other indebtedness, certain events of bankruptcy or insolvency, failure to pay certain judgments, and the cessation of the full force and effect of the guarantees of significant subsidiaries. Generally, if an event of default occurs, the trustee or the holders of at least 25% in principal amount of the then outstanding Senior Notes issued under the relevant Senior Notes Indenture may declare the principal of, and accrued but unpaid interest on, all of the relevant Senior Notes to be due and payable immediately. All provisions regarding remedies in an event of default are subject to the relevant Senior Notes Indenture.
Restrictions and Covenants
As of December 31, 2025, STBV and all of its subsidiaries were subject to certain restrictive covenants under the Credit Agreement and the Senior Notes Indentures.
We entered into the Thirteenth Amendment and Fourteenth Amendment to the Credit Agreement on August 22, 2023 and September 24, 2025, respectively. These amendments each amended the Credit Agreement to, among other things, modify certain of the operational and restrictive covenants and other terms and conditions of the Credit Agreement to provide us increased flexibility and permissions thereunder.
Under certain circumstances, STBV is permitted to designate a subsidiary as "unrestricted" for purposes of the Credit Agreement, in which case the restrictive covenants thereunder will not apply to that subsidiary; the Senior Notes Indentures do not contain such a permission. STBV has not designated any subsidiaries as unrestricted.
Credit Agreement
The Credit Agreement contains non-financial restrictive covenants (subject to important exceptions and qualifications set forth in the Credit Agreement) that limit our ability to, among other things:
•incur indebtedness or liens, prepay subordinated debt, or amend the terms of subordinated debt;
•make loans and investments (including acquisitions) or sell assets;
•change our business or accounting policies, merge, consolidate, dissolve or liquidate, or amend the terms of our organizational documents;
•enter into affiliate transactions;
•pay dividends and make other restricted payments;
•or enter into certain burdensome contractual obligations.
In addition, under the Credit Agreement, STBV and its subsidiaries are required to maintain a senior secured net leverage ratio not to exceed 5.0:1.0 at the conclusion of certain periods when outstanding loans and letters of credit that are not cash collateralized for the full face amount thereof exceed 30% of the total commitments under the Revolving Credit Facility.
Senior Notes Indentures
The Senior Notes Indentures contain restrictive covenants (subject to important exceptions and qualifications set forth in the Senior Notes Indentures) that limit the ability of STBV and its subsidiaries to, among other things: incur liens; incur or
guarantee indebtedness without guaranteeing the Senior Notes; engage in sale and leaseback transactions; or effect mergers or consolidations, or sell, assign, convey, transfer, lease or otherwise dispose of all or substantially all of the assets of STBV and its subsidiaries.
Certain of these covenants will be suspended if the Senior Notes are assigned an investment grade rating by Standard & Poor's Rating Services or Moody's Investors Service, Inc. and provided no default has occurred and is continuing at such time. The suspended covenants will be reinstated if the Senior Notes are no longer assigned an investment grade rating by either rating agency or an event of default has occurred and is continuing at such time. As of December 31, 2025, none of the Senior Notes were assigned an investment grade rating by either rating agency.
Restrictions on Payment of Dividends
STBV's subsidiaries are generally not restricted in their ability to pay dividends or otherwise distribute funds to STBV, except for restrictions imposed under applicable corporate law.
STBV, however, is limited in its ability to pay dividends or otherwise make distributions to its immediate parent company and, ultimately, to Sensata plc, under the Credit Agreement. Specifically, the Credit Agreement prohibits STBV from paying dividends or making distributions to its parent companies other than pursuant to exceptions that include, but are not limited to, the following:
•dividends and other distributions to pay customary and reasonable operating expenses and overhead fees and expenses (including legal and accounting fees and expenses) of such parent companies incurred in the ordinary course of business, provided that such amounts, in the aggregate in any fiscal year, do not exceed the greater of $20.0 million and 2.25% of consolidated EBITDA (as defined in the Credit Agreement) of STBV and its subsidiaries for the trailing four quarters;
•so long as no default or an event of default exists, dividends and other distributions in an aggregate amount not to exceed $50.0 million in any calendar year (with the unused portion in any year being carried over to succeeding years) plus unlimited additional amounts but only insofar as the senior secured net leverage ratio does not exceed 2.5:1.0 calculated on a pro forma basis;
•dividends and other distributions of the “Available Amount” as defined in the Credit Agreement, which includes the cumulative retained portion of excess cash flow during the term of the Credit Agreement, but only insofar as no default or event of default exists and the senior secured net leverage ratio is less than 3.0:1.0 calculated on a pro forma basis;
•dividends and other distributions in an aggregate amount per year not exceeding 7.0% of the trailing 30-trading-day average market capitalization of Sensata plc, so long as no event of default exists at the time of the declaration of any such dividend or at the time of the making of any such other distribution; and
•so long as no default or event of default exists, other dividends and other distributions in an aggregate amount not to exceed the greater of $150.0 million and 20.0% of consolidated EBITDA (as defined in the Credit Agreement) of STBV and its subsidiaries for the trailing four quarters.
The Credit Agreement does not restrict STBV’s parent companies, including Sensata plc, from paying dividends or making other distributions to their shareholders from dividends paid or distributions made to them in compliance with the Credit Agreement.
The Senior Notes Indentures generally allow STBV to pay dividends and make other distributions to its parent companies and do not restrict STBV’s parent companies (including Sensata plc) from paying dividends or making other distributions to their shareholders.
Compliance with Financial Covenants
We were in compliance with all of the financial covenants and default provisions associated with our indebtedness as of December 31, 2025 and for the fiscal year then ended.
Accounting for Debt Financing Transactions
In the year ended December 31, 2024. in connection with the issuance of the 6.625% Senior Notes, we recognized $6.3 million of deferred financing costs, which are presented as a reduction of long-term debt on our consolidated balance sheets.
In connection with the early redemption of our previously outstanding 5.0% Senior Notes due 2025 (the "5.0% Senior Notes"), we recognized a loss of $9.8 million, presented in other, net, which reflects the $7.0 million early redemption premium and $2.8 million related to the write-off of unamortized deferred financing costs and debt discounts.
In the year ended December 31, 2023, in connection with the early redemption of our previously outstanding 5.625% Senior
Notes due 2024 (the "5.0% Senior Notes"), we recognized a loss of $4.6 million, which primarily reflects payment of $4.0 million for the "make-whole" premium, with the remaining loss representing the write-off of debt discounts and deferred financing costs. In connection with the prepayment on the Term Loan, we recognized a loss of $0.9 million, representing the write-off of deferred financing costs. These losses are presented in other, net.
Refer to Note 2: Significant Accounting Policies for additional information related to our accounting policies regarding debt financing transactions.
Finance Leases
Refer to Note 17: Leases for additional information related to our finance leases.
Debt Maturities
The aggregate principal amount of each tranche of our Senior Notes is due in full at its maturity date. Loans made pursuant to the Revolving Credit Facility must be repaid in full at its maturity date and can be repaid prior to then at par. All letters of credit issued thereunder will terminate at the final maturity of the Revolving Credit Facility unless cash collateralized prior to such time.
The following table presents the remaining mandatory principal repayments of long-term debt, excluding finance lease payments and discretionary repurchases of debt, in each of the years ended December 31, 2026 through 2030 and thereafter.
| | | | | |
For the year ended December 31, | Aggregate Maturities |
| 2026 | $ | — | |
| 2027 | — | |
| 2028 | — | |
| 2029 | 646.0 | |
| 2030 | 950.0 | |
| Thereafter | 1,250.0 | |
| Total long-term debt principal payments | $ | 2,846.0 | |
15. Commitments and Contingencies
Off-Balance Sheet Arrangements
From time to time, we execute contracts that require us to indemnify the other parties to the contracts. These indemnification obligations generally arise in two contexts. First, in connection with certain transactions, such as the divestiture of a business or the issuance of debt or equity securities, the agreement typically contains standard provisions requiring us to indemnify the purchaser against breaches by us of representations and warranties contained in the agreement. These indemnities are generally subject to time and liability limitations. Second, we enter into agreements in the ordinary course of business, such as customer contracts, that might contain indemnification provisions relating to product quality, intellectual property infringement, governmental regulations and employment related matters, and other typical indemnities. In certain cases, indemnification obligations arise by law.
We believe that our indemnification obligations are consistent with other companies in the markets in which we compete. Performance under any of these indemnification obligations would generally be triggered by a breach of the terms of the contract or by a third-party claim. Historically, we have experienced only immaterial and irregular losses associated with these indemnifications. Consequently, any future liabilities brought about by these indemnifications cannot reasonably be estimated or accrued.
Indemnifications Provided as Part of Contracts and Agreements
We are party to the following types of agreements pursuant to which we may be obligated to indemnify a third party with respect to certain matters.
Officers and Directors: Our articles of association provide for indemnification of directors and officers by us to the fullest extent permitted by applicable law, as it now exists or may hereinafter be amended (but, in the case of an amendment, only to the extent such amendment permits broader indemnification rights than permitted prior thereto), against any and all liabilities, including all expenses (including attorneys’ fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit, or proceeding, provided he or she acted in good faith and in a
manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful or outside of his or her mandate. The articles do not provide a limit to the maximum future payments, if any, under the indemnification. No indemnification is provided for in respect of any claim, issue, or matter as to which such person has been adjudged to be liable for gross negligence or willful misconduct in the performance of his or her duty on our behalf.
In addition, we have a liability insurance policy that insures directors and officers against the cost of defense, settlement, or payment of claims and judgments under some circumstances. Certain indemnification payments may not be covered under our directors’ and officers’ insurance coverage.
Initial Purchasers of Senior Notes: Pursuant to the terms of the purchase agreements entered into in connection with our private placement senior note offerings, we are obligated to indemnify the initial purchasers of the Senior Notes against certain liabilities caused by any untrue statement or alleged untrue statement of a material fact in various documents relied upon by such initial purchasers, or to contribute to payments the initial purchasers may be required to make in respect thereof. The purchase agreements do not provide a limit to the maximum future payments, if any, under these indemnifications.
Intellectual Property and Product Liability Indemnification: We routinely sell products with a limited intellectual property and product liability indemnification included in the terms of sale. Historically, we have had only immaterial and irregular losses associated with these indemnifications. Consequently, any future liabilities resulting from these indemnifications cannot reasonably be estimated or accrued.
Product Warranty Liabilities
Refer to Note 2: Significant Accounting Policies — Revenue Recognition for additional information related to the warranties we provide to customers.
In the event a warranty claim based on defective materials exists, we may be able to recover some of the cost of the claim from the vendor from whom the materials were purchased. Our ability to recover some of the costs will depend on the terms and conditions to which we agreed when the materials were purchased. When a warranty claim is made, the only collateral available to us is the return of the inventory from the customer making the warranty claim. Historically, when customers make a warranty claim, we either replace the product or provide the customer with a credit. We generally do not rework the returned product.
Our policy is to accrue for warranty claims when a loss is both probable and estimable. This is accomplished by accruing for estimated returns and estimated costs to replace the product at the time the related revenue is recognized. Liabilities for warranty claims are not material. In some instances, customers may make claims for costs they incurred or other damages related to a claim.
Environmental Remediation Liabilities
Our operations and facilities are subject to U.S. and non-U.S. laws and regulations governing the protection of the environment and our employees, including those governing air emissions, chemical usage, water discharges, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites. We could incur substantial costs, including cleanup costs, fines, civil or criminal sanctions, or third-party property damage or personal injury claims, in the event of violations or liabilities under these laws and regulations, or non-compliance with the environmental permits required at our facilities. Potentially significant expenditures could be required in order to comply with environmental laws that may be adopted or imposed in the future. We are, however, not aware of any threatened or pending material environmental investigations, lawsuits, or claims involving us or our operations.
Legal Proceedings and Claims
We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial position, and/or cash flows.
We account for litigation and claims losses in accordance with FASB ASC Topic 450, Contingencies. Under FASB ASC Topic 450, loss contingency provisions are recognized for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined each accounting period as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the minimum amount, which could be an immaterial amount, is recognized. As information becomes known, either
the minimum loss amount is increased, or a best estimate can be made, generally resulting in additional loss provisions. A best estimate amount may be changed to a lower amount when events result in an expectation of a more favorable outcome than previously expected.
Pending Litigation and Claims:
There are no material pending litigation or claims outstanding as of December 31, 2025.
Cybersecurity Incident
In April 2025, we experienced a ransomware incident that encrypted certain devices in our network. The incident temporarily impacted our operations, but the incident did not have a material impact on the Company’s financial results and operations for the year ended 2025.
16. Shareholders' Equity
Purchase of noncontrolling interest in joint venture
In February 2024, we purchased the remaining 50% interest in our joint venture with Dongguan Churod Electronics Co., Ltd. for approximately $79.4 million. Prior to the transaction, we had been consolidating the joint venture. The purchase of the 50% non-controlling interest was accounted for as an equity transaction. No gain or loss was recognized in the consolidated statements of operations. The difference between the fair value of the consideration paid and the amount by which the non-controlling interest was adjusted was recognized as a reduction of additional paid in capital recorded in equity.
Cash Dividends
In the years ended December 31, 2025, 2024, and 2023, we paid cash dividends totaling an aggregate of $70.4 million, $72.2 million, and $71.5 million, respectively.
Foreign Currency Translation
Prior to October 1, 2023, the functional currency of the Company's wholly-owned subsidiaries in China was the USD. Effective October 1, 2023, as a result of significant changes in economic facts and circumstances in the operations of our China foreign entities, the functional currency of the Company's wholly-owned subsidiaries in China changed to the CNY. The changes in economic facts and circumstances caused a permanent change to our strategy in China toward a more self-contained model, making China the primary economic environment in which these subsidiaries operate. This change was accounted for prospectively and does not impact prior period financial statements.
As a result of this change, on October 1, 2023, we recorded an adjustment in other comprehensive income attributable to the current-rate translation of non-monetary assets as of that date in accordance with FASB ASC Topic 830. In addition, in the fourth quarter of 2023, we started recording an adjustment to translate these subsidiaries' financial statements from CNY to USD (our reporting currency). These adjustments are included in other comprehensive income and are presented under the heading Accumulated Other Comprehensive Loss below.
Treasury Shares
From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by our Board of Directors at any time. Under these programs, we may repurchase ordinary shares at such times and in amounts to be determined by our management, based on market conditions, legal requirements, and other corporate considerations, on the open market or in privately negotiated transactions, provided that such transactions were completed pursuant to an agreement and with a third party approved by our shareholders at the annual general meeting. Ordinary shares repurchased by us are recognized, measured at cost, and presented as treasury shares on our consolidated balance sheets, resulting in a reduction of shareholders' equity.
In January 2022, our Board of Directors authorized a $500.0 million ordinary share repurchase program (the “January 2022 Program”), which replaced the previous $500.0 million program approved in July 2019. During the year ended December 31, 2023, we repurchased approximately 1.5 million ordinary shares for $60.3 million (an average price of $40.80 per share), under the January 2022 Program.
On September 26, 2023, our Board of Directors authorized a new $500.0 million ordinary share repurchase program (the “September 2023 Program”), which replaced the January 2022 Program, effective on October 1, 2023. Sensata’s shareholders had previously approved the forms of share repurchase agreements and the potential broker counterparties needed to execute the
buyback program. During the year ended December 31, 2025, we repurchased approximately 4.2 million ordinary shares under the September 2023 Program for $120.6 million (an average price of $28.47 per share). During the year ended December 31, 2024, we repurchased approximately 1.9 million ordinary shares under the September 2023 Program for $68.9 million (an average price of $36.19 per share). During the year ended December 31, 2023, we repurchased approximately 0.8 million ordinary shares under the September 2023 Program for $28.1 million (an average price of $33.83 per share). As of December 31, 2025, approximately $282.4 million remained available under the September 2023 Program.
Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss for the years ended December 31, 2025, 2024, and 2023 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Cash Flow Hedges | | Defined Benefit and Retiree Healthcare Plans | | Cumulative Translation Adjustment | | Accumulated Other Comprehensive Loss |
| Balance as of December 31, 2022 | $ | 15.7 | | | $ | (31.9) | | | $ | — | | | $ | (16.3) | |
| Pre-tax current period change | 2.5 | | | 4.9 | | | 21.4 | | | 28.7 | |
| Income tax effect | (0.6) | | | (1.4) | | | (0.4) | | | (2.5) | |
| Balance as of December 31, 2023 | 17.5 | | | (28.5) | | | 20.9 | | | 10.0 | |
| Pre-tax current period change | (34.3) | | | 7.9 | | | (43.7) | | | (70.1) | |
| Income tax effect | 8.8 | | | 8.9 | | | (0.2) | | | 17.6 | |
| Balance as of December 31, 2024 | (7.9) | | | (11.7) | | | (22.9) | | | (42.5) | |
| Pre-tax current period change | 11.4 | | | 2.0 | | | 25.2 | | | 38.6 | |
| Income tax effect | (2.9) | | | (0.6) | | | — | | | (3.5) | |
| Balance as of December 31, 2025 | $ | 0.5 | | | $ | (10.3) | | | $ | 2.3 | | | $ | (7.4) | |
The components of other comprehensive income, net of tax, for the years ended December 31, 2025, 2024, and 2023 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| | Cash Flow Hedges | | Pension | | CTA | | Total | | Cash Flow Hedges | | Pension | | CTA | | Total | | Cash Flow Hedges | | Pension | | CTA | | Total |
Other comprehensive income/(loss) before reclassifications | | $ | 0.4 | | | $ | 0.9 | | | $ | 25.2 | | | $ | 26.6 | | | $ | (6.4) | | | $ | (0.1) | | | $ | (43.9) | | | $ | (50.4) | | | $ | 30.5 | | | $ | 2.0 | | | $ | 20.9 | | | $ | 53.5 | |
Amounts reclassified from accumulated other comprehensive loss | | 8.0 | | | 0.5 | | | — | | | 8.5 | | | (19.1) | | | 16.9 | | | — | | | (2.1) | | | (28.6) | | | 1.4 | | | — | | | (27.2) | |
Other comprehensive income/(loss) | | $ | 8.4 | | | $ | 1.4 | | | $ | 25.2 | | | $ | 35.1 | | | $ | (25.4) | | | $ | 16.8 | | | $ | (43.9) | | | $ | (52.5) | | | $ | 1.8 | | | $ | 3.4 | | | $ | 20.9 | | | $ | 26.2 | |
The amounts reclassified from accumulated other comprehensive loss for the years ended December 31, 2025, 2024, and 2023 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Amount of (Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | | |
| | For the year ended December 31, | | Affected Line in Consolidated Statements of Operations |
| | 2025 | | 2024 | | 2023 | |
| Derivative instruments designated and qualifying as cash flow hedges: | | | | | | | | |
| Foreign currency forward contracts | | $ | 2.8 | | | $ | (2.3) | | | $ | (17.1) | | | Net revenue (1) |
| Foreign currency forward contracts | | 7.9 | | | (23.4) | | | (21.5) | | | Cost of revenue (1) |
| | | | | | | | |
| Total, before taxes | | 10.7 | | | (25.7) | | | (38.6) | | | Income/(loss) before taxes |
| Income tax effect | | (2.7) | | | 6.6 | | | 10.0 | | | Provision for income taxes |
| Total, net of taxes | | $ | 8.0 | | | $ | (19.1) | | | $ | (28.6) | | | Net income/(loss) |
| | | | | | | | |
| Defined benefit and retiree healthcare plans | | $ | — | | | $ | 0.7 | | | $ | 1.9 | | | Other, net |
| Defined benefit and retiree healthcare plans | | 0.7 | | | 6.2 | | | — | | | Restructuring and other charges, net |
| Total, before taxes | | 0.7 | | | 6.9 | | | 1.9 | | | Income/(loss) before taxes |
| Income tax effect | | (0.2) | | | 10.0 | | | (0.5) | | | Provision for income taxes |
| Total, net of taxes | | $ | 0.5 | | | $ | 16.9 | | | $ | 1.4 | | | Net income/(loss) |
__________________________
(1) Refer to Note 19: Derivative Instruments and Hedging Activities for additional information related to amounts to be reclassified from accumulated other comprehensive loss in future periods.
17. Leases
The table below shows right-of-use asset and lease liability amounts and the financial statement line item in which those amounts are presented:
| | | | | | | | | | | |
| As of December 31, |
| | 2025 | | 2024 |
| Operating lease right-of-use assets: | | | |
| Other assets | $ | 51.7 | | | $ | 37.8 | |
| Total operating lease right-of-use assets | $ | 51.7 | | | $ | 37.8 | |
| Operating lease liabilities: | | | |
| Accrued expenses and other current liabilities | $ | 15.7 | | | $ | 13.1 | |
| Other long-term liabilities | 57.1 | | | 44.9 | |
| Total operating lease liabilities | $ | 72.8 | | | $ | 58.0 | |
| Finance lease right-of-use assets: | | | |
| Property, plant and equipment, at cost | $ | 44.9 | | | $ | 44.9 | |
| Accumulated depreciation | (31.1) | | | (30.3) | |
| Property, plant and equipment, net | $ | 13.7 | | | $ | 14.6 | |
| Finance lease liabilities: | | | |
Current portion of long-term debt and finance lease obligations | $ | 2.3 | | | $ | 2.4 | |
Finance lease obligations, less current portion | 18.9 | | | 21.0 | |
| Total finance lease liabilities | $ | 21.2 | | | $ | 23.4 | |
The table below presents the lease liabilities arising from obtaining right-of-use assets in the years ended December 31, 2025 and 2024:
| | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 |
| Operating leases | $ | 22.6 | | | $ | 28.1 | |
| Finance leases | $ | — | | | $ | — | |
The table below presents our total lease cost for the years ended December 31, 2025, 2024, and 2023 (short-term and variable lease cost was not material for any of the years presented):
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
Operating lease cost (a) | $ | 18.5 | | | $ | 35.5 | | | $ | 15.2 | |
| | | | | |
| Finance lease cost: | | | | | |
| Amortization of right-of-use assets | $ | 1.3 | | | $ | 1.3 | | | $ | 1.5 | |
| Interest on lease liabilities | 1.9 | | | 2.1 | | | 2.2 | |
| Total finance lease cost | $ | 3.2 | | | $ | 3.4 | | | $ | 3.7 | |
__________________________(a) For the year ended December 31, 2024, total operating lease cost includes accelerated right-of-use asset amortization of $20.3 million for specific operating leases that we had abandoned.
The table below presents the cash paid related to our operating and finance leases for the years ended December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Operating cash outflow related to operating leases | $ | 18.0 | | | $ | 16.0 | | | $ | 15.4 | |
| Operating cash outflow related to finance leases | $ | 2.0 | | | $ | 1.9 | | | $ | 2.0 | |
| Financing cash outflow related to finance leases | $ | 2.2 | | | $ | 1.9 | | | $ | 1.5 | |
The table below presents the weighted-average remaining lease term of our operating and finance leases (in years) as of December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| | 2025 | | 2024 | | 2023 |
| Operating leases | 8.2 | | 7.1 | | 6.0 |
| Finance leases | 7.5 | | 8.4 | | 9.3 |
The table below presents our weighted-average discount rate as of December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| | 2025 | | 2024 | | 2023 |
| Operating leases | 6.1 | % | | 5.8 | % | | 5.6 | % |
| Finance leases | 8.8 | % | | 8.8 | % | | 8.7 | % |
The table below presents a maturity analysis of the obligations related to our operating lease liabilities and finance lease liabilities in effect as of December 31, 2025:
| | | | | | | | | | | |
Year ending December 31, | Operating Leases | | Finance Leases |
| | | |
| 2026 | $ | 15.7 | | | $ | 3.9 | |
| 2027 | 12.6 | | | 4.0 | |
| 2028 | 9.6 | | | 3.8 | |
| 2029 | 8.3 | | | 3.4 | |
| 2030 | 6.6 | | | 3.4 | |
| Thereafter | 32.0 | | | 10.8 | |
| Total undiscounted cash flows related to lease liabilities | 84.8 | | | 29.3 | |
| Less imputed interest | (12.0) | | | (8.1) | |
| Total lease liabilities | $ | 72.8 | | | $ | 21.2 | |
18. Fair Value Measures
Our assets and liabilities recorded at fair value have been categorized based upon a fair value hierarchy in accordance with FASB ASC Topic 820. The levels of the fair value hierarchy are described below:
•Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets and liabilities that we have the
ability to access at the measurement date.
•Level 2 inputs utilize inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, and inputs other than quoted prices that are observable for the asset or liability, such as interest rates and yield curves that are observable at commonly quoted intervals.
•Level 3 inputs are unobservable inputs for the asset or liability, allowing for situations where there is little, if any, market activity for the asset or liability.
Measured on a Recurring Basis
Our assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 and 2024 are shown in the below table.
| | | | | | | | | | | |
| As of December 31, |
| | 2025 | | 2024 |
| Assets measured at fair value: | | | |
Cash equivalents (Level 1) | $ | 406.1 | | | $ | 243.6 | |
Foreign currency forward contracts (Level 2) | 18.3 | | | 19.1 | |
Commodity forward contracts (Level 2) | 21.2 | | | 1.5 | |
| Total assets measured at fair value | $ | 445.6 | | | $ | 264.2 | |
| Liabilities measured at fair value: | | | |
Foreign currency forward contracts (Level 2) | $ | 17.4 | | | $ | 27.6 | |
Commodity forward contracts (Level 2) | 0.3 | | | 1.3 | |
| Total liabilities measured at fair value | $ | 17.7 | | | $ | 28.9 | |
Refer to Note 2: Significant Accounting Policies for additional information related to the methods used to estimate the fair value of our financial instruments and Note 19: Derivative Instruments and Hedging Activities for additional information related to the inputs used to determine these fair value measurements and the nature of the risks that these derivative instruments are intended to mitigate. Cash equivalents consist of U.S. Government Treasury money market funds and are classified as Level 1 as they are exchange traded in an active market.
Although we have determined that the majority of the inputs used to value our derivative instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads, to appropriately reflect both our own non-performance risk and the respective counterparties' non-performance risk in the fair value measurement. As of December 31, 2025 and 2024, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions and have determined that the credit valuation adjustments are not significant to the overall valuation of our derivatives. As a result, we have determined that our derivatives in their entirety are classified in Level 2 in the fair value hierarchy.
Measured on a Nonrecurring Basis
In the third quarter of 2025, impairment indicators were identified that suggested the carrying value of the Dynapower reporting unit could exceed its fair value. The primary indicators of impairment were a lower outlook within certain markets that the reporting unit operates in following recent tax legislation being enacted, and a strategic shift to focus on other markets. This revised outlook led to downward revisions of forecasted future cash flows. We evaluated the goodwill of the Dynapower reporting unit for impairment using a combination of a market-based valuation method and an income approach that discounts forecasted cash flows. As these assumptions were largely unobservable, the estimated fair values fall within Level 3 of the fair value hierarchy. A change in our cash flow forecast or the discount rate used would result in an increase or decrease in our calculated fair value. We determined that our Dynapower reporting unit was impaired, and in the third quarter of 2025, we recorded a $225.7 million non-cash impairment charge. If Dynapower does not achieve the forecasted future cash flows, there is a possibility that additional impairments of the remaining $4.1 million of goodwill may be recognized in the future.
In the third quarter of 2024, we determined that our Dynapower reporting unit was impaired, and we recorded a $150.1 million non-cash impairment charge. In the fourth quarter of 2023, we determined that our Insights reporting unit was impaired and we recorded a $321.7 million non-cash impairment charge. Refer to Note 11: Goodwill and Other Intangible Assets, Net for additional information.
As of December 31, 2025, no events or changes in circumstances occurred that would have triggered the need for an additional impairment review of goodwill or other indefinite-lived intangible assets. We evaluated our goodwill for impairment as of October 1, 2025 using a qualitative analysis that considered events and circumstances affecting the fair value of each reporting unit, including macroeconomic conditions, market conditions, industry trends, cost factors, financial performance, and other relevant qualitative factors. The results did not indicate a need to perform quantitative analysis, as we determined that it is more likely than not that the fair value of each of our reporting units exceeded their respective carrying values. Refer to Note 11: Goodwill and Other Intangible Assets, Net for additional information.
Financial Instruments Not Recorded at Fair Value
The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the consolidated balance sheets as of December 31, 2025 and 2024. All fair value measures presented are categorized within Level 2 of the fair value hierarchy.
| | | | | | | | | | | | | | | | | | | | | | | |
| As of December 31, |
| | 2025 | | 2024 |
| Carrying Value (1) | | Fair Value | | Carrying Value (1) | | Fair Value |
| | | | | | | |
| | | | | | | |
| | | | | | | |
4.0% Senior Notes | $ | 646.0 | | | $ | 632.2 | | | $ | 1,000.0 | | | $ | 915.0 | |
4.375% Senior Notes | $ | 450.0 | | | $ | 439.8 | | | $ | 450.0 | | | $ | 410.6 | |
5.875% Senior Notes | $ | 500.0 | | | $ | 507.9 | | | $ | 500.0 | | | $ | 485.0 | |
3.75% Senior Notes | $ | 750.0 | | | $ | 703.1 | | | $ | 750.0 | | | $ | 652.5 | |
| | | | | | | |
| | | | | | | |
6.625% Senior Notes | $ | 500.0 | | | $ | 523.8 | | | $ | 500.0 | | | $ | 497.5 | |
__________________________
(1) Excluding any related debt discounts, premiums, and deferred financing costs.
We also hold trade accounts receivables and payables, for which the fair value approximates the carrying value due to their short-term nature.
As of December 31, 2025 and 2024, we held equity investments under the measurement alternative of $7.3 million and $6.1 million, respectively, which are presented in other assets in the consolidated balance sheets. In the year ended December 31, 2024, we adjusted the carrying value of one of these equity investments as a result of an observable price change in the first quarter of 2024, resulting in a loss of $14.8 million.
19. Derivative Instruments and Hedging Activities
We utilize derivative instruments that are designated and qualify as hedges of our exposure to variability in expected future cash flows. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on these hedging instruments with the earnings effect of the hedged forecasted transactions. We may enter into other derivative contracts that are intended to economically hedge certain risks, even though we elect not to apply hedge accounting under FASB ASC Topic 815. Derivative financial instruments not designated as hedges are used to manage our exposure to certain risks, not for trading or speculative purposes. Refer to Note 2: Significant Accounting Policies for additional information related to the valuation techniques and accounting policies regarding derivative instruments and hedging activities.
Foreign Currency Risk
We are exposed to fluctuations in the values of certain foreign currencies relative to the functional currency of a given entity. We enter into forward contracts to manage this exposure. We currently have outstanding foreign currency forward contracts that qualify as cash flow hedges intended to offset the effect of exchange rate fluctuations on forecasted sales and certain manufacturing costs. We also have outstanding foreign currency forward contracts that are intended to preserve the economic value of foreign currency denominated monetary assets and liabilities, which are not designated for hedge accounting treatment in accordance with FASB ASC Topic 815.
For each of the years ended December 31, 2025, 2024, and 2023, amounts excluded from the assessment of effectiveness of our foreign currency forward contracts that are designated as cash flow hedges were not material. As of December 31, 2025, we estimate that $2.4 million of net losses will be reclassified from accumulated other comprehensive loss to earnings during the twelve-month period ending December 31, 2026.
As of December 31, 2025, we had the following outstanding foreign currency forward contracts:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Notional (in millions) | | Effective Date(s) | | Maturity Date(s) | | Index (Exchange Rates) | | Weighted- Average Strike Rate | | Hedge Designation (1) |
| | | | | | | | | | |
| 397.4 EUR | | Various from January 2024 to December 2025 | | Various from January 2026 to December 2027 | | Euro ("EUR") to USD | | 1.15 USD | | Cash flow hedge |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| 3,822.4 MXN | | Various from January 2024 to December 2025 | | Various from January 2026 to December 2027 | | USD to Mexican Peso ("MXN") | | 20.45 MXN | | Cash flow hedge |
| | | | | | | | | | |
| 67.6 GBP | | Various from January 2024 to December 2025 | | Various from January 2026 to December 2027 | | British Pound Sterling ("GBP") to USD | | 1.31 USD | | Cash flow hedge |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Notional (in millions) | | Effective Date(s) | | Maturity Date(s) | | Index (Exchange Rates) | | Weighted- Average Strike Rate | | Hedge Designation (1) |
| | | | | | | | | | |
| | | | | | | | | | |
| 60.3 USD | | Various from March 2024 to May 2024 | | Various from January 2026 to May 2026 | | USD to Chinese Renminbi ("CNY") | | 6.97 CNY | | Not designated |
| 420.5 CNY | | Various September 2024 | | Various from January 2026 to May 2026 | | USD to CNY | | 6.77 CNY | | Not designated |
| | | | | | | | | | |
| 8,657.0 KRW | | Various from February 2024 to September 2024 | | Various from January 2026 to July 2026 | | USD to Korean Won ("KRW") | | 1,315.03 KRW | | Not designated |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
__________________________
(1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve the economic value, and they are not used for trading or speculative purposes. We may also enter into intercompany derivative instruments with our wholly-owned subsidiaries in order to hedge certain forecasted expenses.
Financial Instrument Presentation
The following table presents the fair value of our derivative financial instruments and their classification in the consolidated balance sheets as of December 31, 2025 and 2024:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Asset Derivatives | | Liability Derivatives |
| | Balance Sheet Location | | As of December 31, | | Balance Sheet Location | | As of December 31, |
| | | | 2025 | | 2024 | | | 2025 | | 2024 |
| Derivatives designated as hedging instruments: | | | | | | | | | | |
| Foreign currency forward contracts | | Prepaid expenses and other current assets | | $ | 14.9 | | | $ | 15.8 | | | Accrued expenses and other current liabilities | | $ | 13.8 | | | $ | 17.0 | |
| Foreign currency forward contracts | | Other assets | | 3.4 | | | 2.9 | | | Other long-term liabilities | | 1.7 | | | 4.1 | |
| Total | | | | $ | 18.3 | | | $ | 18.7 | | | | | $ | 15.5 | | | $ | 21.1 | |
| Derivatives not designated as hedging instruments: | | | | | | | | | | |
| Commodity forward contracts | | Prepaid expenses and other current assets | | $ | 17.0 | | | $ | 1.4 | | | Accrued expenses and other current liabilities | | $ | 0.3 | | | $ | 0.9 | |
| Commodity forward contracts | | Other assets | | 4.2 | | | 0.1 | | | Other long-term liabilities | | — | | | 0.4 | |
| Foreign currency forward contracts | | Prepaid expenses and other current assets | | 0.4 | | | 0.4 | | | Accrued expenses and other current liabilities | | 2.3 | | | 4.8 | |
| Foreign currency forward contracts | | Other assets | | — | | | — | | | Other long-term liabilities | | — | | | 1.8 | |
| Total | | | | $ | 21.6 | | | $ | 1.9 | | | | | $ | 2.6 | | | $ | 7.9 | |
These fair value measurements are all categorized within Level 2 of the fair value hierarchy. Refer to Note 18: Fair Value Measures for additional information related to the categorization of these fair value measurements within the fair value hierarchy.
The following tables present the effect of our derivative financial instruments on the consolidated statements of operations and the consolidated statements of comprehensive income for the years ended December 31, 2025 and 2024:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Derivatives designated as hedging instruments | | Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive (Loss)/ Income | | Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/ (Loss) | | Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) |
| For the year ended December 31, | | | For the year ended December 31, |
| 2025 | | 2024 | | | 2025 | | 2024 |
| Foreign currency forward contracts | | $ | (36.4) | | | $ | 27.9 | | | Net revenue | | $ | (2.8) | | | $ | 2.3 | |
| Foreign currency forward contracts | | $ | 37.1 | | | $ | (36.5) | | | Cost of revenue | | $ | (7.9) | | | $ | 23.4 | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
| Derivatives not designated as hedging instruments | | Amount of (Loss)/Gain Recognized in Net Income/Loss) | | Location of (Loss)/Gain Recognized in Net Income/(Loss) |
| For the year ended December 31, | |
| 2025 | | 2024 | |
| Commodity forward contracts | | $ | 28.1 | | | $ | 3.5 | | | Other, net |
| Foreign currency forward contracts | | $ | (2.5) | | | $ | (2.6) | | | Other, net |
Credit risk related contingent features
We have agreements with our derivative counterparties that contain a provision whereby if we default on our indebtedness and repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations.
As of December 31, 2025, the termination value of outstanding derivatives in a liability position, excluding any adjustment for non-performance risk, was $18.2 million. As of December 31, 2025, we have not posted any cash collateral related to these agreements. If we breach any of the default provisions on any of our indebtedness as described above, we could be required to settle our obligations under the derivative agreements at their termination values.
20. Segment Reporting
We present financial information for three reportable segments, Automotive, Industrials, and Aerospace, Defense, and Commercial Equipment. Also, in the last quarter of 2025, we realigned our segments as a result of organizational changes that better allocate our resources to support changes to our business strategy. Refer to Note 1: Basis of Presentation for additional information. Our operating segments are business segments that we manage as components of an enterprise, for which separate financial information is evaluated regularly by our chief operating decision maker ("CODM"), who is our chief executive officer, in deciding how to allocate resources and assess performance.
An operating segment’s performance is primarily evaluated based on segment operating income, which excludes amortization of intangible assets, impairment of goodwill and other intangible assets, restructuring charges, and certain corporate costs or credits not associated with the operations of the segment. Corporate and other costs excluded from a segment’s performance are separately stated below and include costs that are related to functional areas such as finance, information technology, legal, and human resources. The CODM uses operating income primarily in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for operating income when making decisions about the allocation of operating and capital resources to each segment. Significant expenses reviewed by the CODM are segment cost of revenue and segment operating expenses. We believe that segment operating income, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, the measure should be considered in addition to, and not as a substitute for, or superior to, operating income or other measures of financial performance prepared with U.S. GAAP. The accounting policies of each of our operating and reportable segments are materially consistent with those described in Note 2: Significant Accounting Policies.
The Automotive segment primarily serves the Automotive OEM and aftermarket industries through the development and manufacturing of sensors, high-voltage solutions (i.e., electrical protection components), and other solutions that are used in mission-critical systems and applications.
Industrials primarily serves industrial customers through the development and manufacture of a broad portfolio of application-specific sensor, power management, and electrical protection products used in a diverse range of industrial markets, including the appliance, HVAC, material handling, charging infrastructure, renewable energy generation, and microgrid applications and
markets.
The Aerospace, Defense, and Commercial Equipment primarily serves the aerospace, including commercial aircraft, defense, and commercial equipment, which includes on-road truck, construction, and agriculture markets, through the development and manufacture of a variety of sensors, electrical protection products, operator controls, and other solutions that are used in mission-critical systems and applications.
The following table presents net revenue, cost of revenue, segment and non-segment operating expenses, and segment and non-segment operating income for the reportable segments and other operating results not allocated to the reportable segments for the years ended December 31, 2025, 2024, and 2023. The net revenue and segment operating income and corporate and other amounts previously reported in the table below for the years ended December 31, 2025, 2024, and 2023 have been retrospectively recast to reflect the segment realignments as described above.
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Net revenue: | | | | | |
Automotive (1) | $ | 2,111.7 | | | $ | 2,195.5 | | | $ | 2,167.4 | |
Industrials (1) | 787.8 | | | 749.2 | | | 863.2 | |
Aerospace, Defense, and Commercial Equipment (1) | 805.0 | | | 860.2 | | | 876.1 | |
Other | — | | | 127.9 | | | 147.5 | |
| Total net revenue | $ | 3,704.5 | | | $ | 3,932.8 | | | $ | 4,054.1 | |
Segment and non-segment cost of revenue: | | | | | |
Automotive | $ | 1,456.2 | | | $ | 1,506.8 | | | $ | 1,480.9 | |
Industrials | 469.3 | | | 454.0 | | | 528.3 | |
Aerospace, Defense, and Commercial Equipment | 524.0 | | | 549.0 | | | 542.5 | |
| Other | — | | | 72.8 | | | 90.2 | |
Total segment and non-segment cost of revenue | $ | 2,449.5 | | | $ | 2,582.6 | | | $ | 2,641.8 | |
Segment and non-segment operating expenses(2): | | | | | |
Automotive (1) | $ | 154.8 | | | $ | 181.2 | | | $ | 175.9 | |
Industrials (1) | 92.4 | | | 102.9 | | | 116.3 | |
Aerospace, Defense, and Commercial Equipment (1) | 69.5 | | | 84.6 | | | 93.7 | |
| Other | — | | | 27.1 | | | 49.8 | |
| Total segment and non-segment operating expenses | $ | 316.6 | | | $ | 395.8 | | | $ | 435.6 | |
| Segment and non-segment operating income (as defined above): | | | | | |
Automotive (1) | $ | 500.8 | | | $ | 507.5 | | | $ | 510.7 | |
Industrials (1) | 226.0 | | | 192.3 | | | 218.6 | |
Aerospace, Defense, and Commercial Equipment (1) | 211.5 | | | 226.5 | | | 239.9 | |
Other | — | | | 28.1 | | | 7.5 | |
| Total segment and non-segment operating income | 938.4 | | | 954.4 | | | 976.7 | |
Corporate and other (1) | (344.1) | | | (360.1) | | | (245.0) | |
| Amortization of intangible assets | (80.2) | | | (145.7) | | | (173.9) | |
Goodwill impairment charge | (225.7) | | | (150.1) | | | (321.7) | |
| Restructuring and other charges, net | (50.8) | | | (149.2) | | | (54.5) | |
| Operating income | 237.5 | | | 149.3 | | | 181.7 | |
| Interest expense | (149.1) | | | (155.8) | | | (182.2) | |
| Interest income | 19.1 | | | 16.2 | | | 31.3 | |
| Other, net | 15.8 | | | (21.5) | | | (13.0) | |
Income/(loss) before taxes | $ | 123.3 | | | $ | (11.8) | | | $ | 17.8 | |
___________________________________
(1) The amounts previously reported for the years ended December 31, 2024 and 2023 have been retrospectively recast to reflect the segment realignment as discussed in Note 1: Basis of Presentation.
(2) Segment operating expenses include research, development, and engineering, and selling, general and administrative expenses associated with each segment.
The following table presents depreciation and amortization expense for our reportable segments and corporate and other for the years ended December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Depreciation and amortization: | | | | | |
Automotive | $ | 88.6 | | | $ | 80.0 | | | $ | 82.3 | |
Industrials | 12.8 | | | 11.5 | | | 13.5 | |
Aerospace, Defense, and Commercial Equipment | 17.8 | | | 18.1 | | | 18.6 | |
Corporate and other (1) | 137.2 | | | 203.2 | | | 192.6 | |
| Total depreciation and amortization | $ | 256.4 | | | $ | 312.8 | | | $ | 307.0 | |
__________________________
(1)Included within corporate and other is depreciation expense associated with the step-up in fair value of assets acquired in connection with a business combination (e.g., PP&E and inventories), amortization of intangible assets, and accelerated depreciation recognized in connection with restructuring actions. We do not allocate these amounts to our segments. This treatment is consistent with the financial information reviewed by our chief operating decision maker.
The following table presents additions to PP&E and capitalized software for our reportable segments and corporate and other for the years ended December 31, 2025, 2024, and 2023:
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Additions to property, plant and equipment and capitalized software: | | | | | |
Automotive | $ | 93.9 | | | $ | 113.2 | | | $ | 129.8 | |
Industrials | 14.5 | | | 16.4 | | | 18.1 | |
Aerospace, Defense, and Commercial Equipment | 3.9 | | | 2.8 | | | 3.6 | |
| Corporate and other | 18.9 | | | 26.2 | | | 33.1 | |
| Total additions to property, plant and equipment and capitalized software | $ | 131.2 | | | $ | 158.6 | | | $ | 184.6 | |
Geographic Area Information
The following tables present net revenue by geographic area and by significant country for the years ended December 31, 2025, 2024, and 2023. In these tables, net revenue is aggregated according to the location of our subsidiaries.
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Net revenue: | | | | | |
| Americas | $ | 1,499.7 | | | $ | 1,702.0 | | | $ | 1,825.0 | |
| Europe | 1,013.5 | | | 1,061.6 | | | 1,066.1 | |
| Asia and rest of world | 1,191.3 | | | 1,169.2 | | | 1,163.0 | |
| Net revenue | $ | 3,704.5 | | | $ | 3,932.8 | | | $ | 4,054.1 | |
| | | | | | | | | | | | | | | | | |
| | For the year ended December 31, |
| | 2025 | | 2024 | | 2023 |
| Net revenue: | | | | | |
| United States | $ | 1,445.2 | | | $ | 1,574.0 | | | $ | 1,678.5 | |
| China | 745.4 | | | 724.0 | | | 724.7 | |
| The Netherlands | 861.7 | | | 897.1 | | | 904.2 | |
| | | | | |
| United Kingdom | 116.4 | | | 127.2 | | | 105.2 | |
| All other | 535.8 | | | 610.5 | | | 641.5 | |
| Net revenue | $ | 3,704.5 | | | $ | 3,932.8 | | | $ | 4,054.1 | |
The following tables present PP&E, net, by geographic area and by significant country as of December 31, 2025 and 2024. In these tables, PP&E, net is aggregated based on the location of our subsidiaries.
| | | | | | | | | | | |
| | As of December 31, |
| | 2025 | | 2024 |
| Property, plant and equipment, net: | | | |
| Americas | $ | 262.3 | | | $ | 301.9 | |
| Europe | 135.4 | | | 141.4 | |
| Asia and rest of world | 378.7 | | | 378.4 | |
| Property, plant and equipment, net | $ | 776.5 | | | $ | 821.7 | |
| | | | | | | | | | | |
| | As of December 31, |
| | 2025 | | 2024 |
| Property, plant and equipment, net: | | | |
| United States | $ | 99.4 | | | $ | 121.8 | |
| China | 254.3 | | | 266.1 | |
| Mexico | 162.8 | | | 180.0 | |
| Bulgaria | 99.4 | | | 108.1 | |
| United Kingdom | 24.6 | | | 21.1 | |
| Malaysia | 120.5 | | | 108.1 | |
| All other | 15.5 | | | 16.5 | |
| Property, plant and equipment, net | $ | 776.5 | | | $ | 821.7 | |
21. Divestitures
Insights Business
In August 2024, we executed a purchase agreement whereby we agreed to sell the Insights Business to an affiliate of Balmoral Funds ("the Buyer"). The closing of the transaction occurred in the third quarter of 2024, at which time net assets transferred to the Buyer.
For the year ended December 31, 2024 and 2023 the Insights Business was included in Other. Refer to Note 1: Basis of Presentation and Note 20: Segment Reporting included elsewhere in this Report for additional information on the segment realignment.
Magnetic Speed and Position Business ("MSP Business")
In November 2024, we executed a purchase agreement whereby we agreed to sell the MSP Business to a third party. The closing of the transaction occurred in the first quarter of 2025, at which time net assets transferred to the buyer.
22. Subsequent Events
In February 2026, the United States Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act. We have incurred, and passed through to customers, approximately $40.8 million of tariffs during the year ended December 31, 2025. The ultimate availability, timing, and amount of any potential refunds of such tariffs remain highly uncertain and are subject to further legal, regulatory, and administrative developments. There remains substantial uncertainty regarding the duration of existing and newly announced tariffs, potential changes or pauses to such tariffs, tariff levels, and whether further additional tariffs or other retaliatory actions may be imposed, modified, or suspended, and the impacts of such actions on our business.